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ABSTRACT 
 
BARRIERS AND FACILITATORS TO DIABETES SELF-MANAGEMENT IN A PRIMARY 
CARE SETTING – PATIENT AND PHYSICIAN PERSPECTIVES 
 
 
 
By 
Rahul Khairnar 
May 2017 
 
Thesis Supervised by Dr. Khalid M. Kamal 
OBJECTIVES: To identify patient- and physician-perceived barriers to self-management of 
type-2 diabetes (T2DM) and explore the challenges physicians face in managing these patients.  
METHODS: This cross-sectional study of T2DM patients and their physicians used a mixed-
methods approach (combination of patient survey and electronic medical record (EMR) 
database). A random stratified sample of 2,100 patients (age≥18 years) with a recorded diagnosis 
of T2DM (ICD-9 code: 250.xx) and having ≥2 physician visits was selected from a large 
physician group’s EMR database, and based on HbA1c level, was categorized into three groups: 
HbA1c<7, 7–9, and >9. Patients were administered a survey containing standardized instruments 
to collect information on demographics and diabetes self-care behaviors. Physician survey 
measured physician perceptions of patient barriers to self-management and their challenges in 
managing uncontrolled T2DM patients.  RESULTS: 210 responses were received (10% 
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response rate). Mean age was 63.68 years (+/-11.79), 102 (48.6%) were females, 197 were 
Caucasian (93.8%). Univariate analysis revealed that age (X2=15.73, p<0.01), insurance status 
(X2=12.03, p<0.05), referral to an endocrinologist (X2=6.17, p<0.05), level of self-management 
(X2=12.01, p<0.05), and willingness to take insulin (X2=9.8, p<0.01) were associated with 
HbA1c control.  Older age, lower willingness to take insulin, and less than graduate level 
education were significant determinants of glycemic control. Of the 21 physicians who 
responded (53.8% response rate), 71.2% were over the age of 50 years, 54.16% had ≥25 years of 
clinical experience, and 50% practiced in an urban setting. Barriers leading to clinical inertia as 
identified by the physicians include cost of medications, non-compliance with diet and 
medications, polypharmacy, lack of patient motivation, knowledge, time, and social support.  
CONCLUSIONS: Self-management behavior of T2DM patients is strongly associated with 
HbA1c control. Interventions directed towards improving self-management in T2DM population 
that take both physician and patient perspectives in to consideration may result in improved 
clinical outcomes. 
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CHAPTER ONE – INTRODUCTION 
Diabetes Mellitus – An Overview 
Diabetes Mellitus (DM), or simply Diabetes, is a group of metabolic disorders 
characterized by inefficient utilization of blood glucose.1 Glucose is the primary source of energy 
for the body. Insulin, a hormone secreted by pancreas, facilitates the uptake of blood glucose by 
body cells and tissues. In a healthy individual, the pancreas secretes adequate amounts of insulin 
required for this blood glucose transfer. This secretion is triggered by the amount of food 
consumed by an individual. In an individual with DM, there is either little or no production of 
insulin by the pancreas, or improper utilization of insulin by body cells, or a combination of 
both.2  
The three most commonly recognized forms of diabetes are as follows3: 
1. Type 1 Diabetes Mellitus (T1DM) OR Insulin Dependent Diabetes Mellitus (IDDM) 
2. Type 2 Diabetes Mellitus (T2DM) OR Non-Insulin Dependent Diabetes Mellitus 
(NIDDM) 
3. Gestational Diabetes 
T1DM is an autoimmune disorder where the body produces antibodies against its own 
pancreas. These antibodies damage the pancreas and stop insulin production. The etiology of 
T1DM is unclear. It may be caused by genetic predisposition, environmental factors, or as a 
result of faulty beta cells in the pancreas which normally produce insulin.1 T1DM accounts for 
around 5 – 10% of the diagnosed cases of diabetes in the United States (US).3 
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T2DM, also known as Non-Insulin Dependent Diabetes Mellitus (NIDDM), is the most 
common form of diabetes accounting for around 90% of the 26 million Americans with diabetes. 
It occurs due to insufficient or no production of insulin by the pancreas, or ineffective utilization 
of insulin by body cells due to insulin resistance.  It has been observed that African Americans, 
Latinos, Native Americans, and Asian Americans (Pacific Islanders) are at an increased risk of 
developing T2DM.2 Aging, obesity, family history of diabetes, previous history of gestational 
diabetes, and physical inactivity are other factors associated with T2DM. Over 80% of the 
patients with T2DM are overweight.4 
Gestational diabetes is a form of glucose intolerance that occurs in 2 – 10% of pregnant 
women due to pregnancy.5 It can cause several health problems during pregnancy, to both 
mother and child. Women with gestational diabetes and their children are at an increased risk of 
developing T2DM in the future. Women with gestational diabetes have 35 – 60% chance of 
developing T2DM in the next 10 – 20 years while 5 – 10% of women with gestational diabetes 
are found to have T2DM after pregnancy.5 
Diabetes Mellitus (DM) is one of the primary causes of heart disease and stroke. 
According to the Centers for Disease Control (CDC) Diabetes Report Card 2012, adults with 
diabetes have 2- to 4-fold higher mortality rate for heart disease and 2- to 4-fold higher risk of 
stroke. Hypertension is the most common co-morbidity associated with diabetes with around 
67% of the adults with DM reported to have hypertension. Diabetes is also associated with other 
complications such as blindness, kidney failure, gangrene and amputations of the lower limbs.5 
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Type-2 Diabetes Mellitus (T2DM) 
T2DM is a chronic metabolic disorder that affects over 25.8 million people in the US 
with an estimated seven million people remaining undiagnosed.5 An alarming 79 million people 
are reported to be in the pre-diabetes phase and have an increased likelihood of suffering from 
diabetes in the future.5 T2DM is attaining epidemic proportions and in 2010 alone, 1.9 million 
incident cases of diabetes were reported, almost three times as much in 1990.5 This sudden rise 
in the incidence of T2DM is associated with an increase in obesity, decrease in leisure-time 
physical activity, and aging population.5, 6 Diabetes was the sixth leading cause of death in the 
US in 2002. In 2010 alone, 69,071 certificates listed diabetes as the underlying cause of death, 
while it was mentioned as a cause of death in over 234,051 death certificates. The true extent of 
the effect of diabetes, however, is likely to be underestimated as diabetes-related deaths are often 
attributed to other causes.7 Studies show that diabetes was listed as a cause of death in 35 - 40% 
of people with diabetes while only 10 -15% had it listed as the underlying cause of death.2, 7   
Elevated blood glucose levels, a defining characteristic of diabetes, is associated with 
increases in blood pressure and dyslipidemia. These lead to long-term complications such as 
cardiovascular disease, diabetic neuropathy, diabetic retinopathy, kidney disease, gangrene and 
amputation of lower limbs. These complications are primarily responsible for the increased 
mortality and morbidity in patients with diabetes.7  The risk of death is approximately 2 times 
higher in people with diabetes, as compared to those without it.7 Given the chronic nature of 
diabetes, the economic impact associated with the disease is substantial. The total healthcare cost 
for people with diabetes is 2.3 times higher compared to those without diabetes.6 In 2012, 
diabetes (only diagnosed cases) cost the nation a total of $245 billion, of which $176 billion were 
direct medical costs while $69 billion were due to loss in productivity.5 The American Diabetes 
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Association (ADA) has predicted a significant rise in the number of people having diabetes in 
the coming decades, which would further impose a huge burden on the allocation of healthcare 
dollars.5  
Diabetes Self-Management 
‘Diabetes self-management (DSM),’ an essential component of diabetes care, is defined 
as the ability to manage the symptoms, treatment, and lifestyle changes inherent in living with a 
chronic condition.8 DSM involves modifying health behaviors (incorporate changes in daily plan 
when necessary) to suit the treatment regimen and completion of self-care activities such as 
following a regular diet and exercise plan, self-monitoring of blood glucose levels, and 
adherence to medication.9 There is strong evidence linking DSM with optimal glycemic control, 
enhanced quality of life and improved psychosocial functions.8 However, it is important to note 
that DSM by itself is not sufficient in managing T2DM and the patients may eventually require 
pharmacologic treatment(s) along with DSM to effectively manage and control their disease. 
Diabetes complications such as obesity, gangrene, neuropathy (peripheral or autonomic), 
retinopathy and poor renal function are often debilitating, costly, and could be fatal. These 
complications are more common and more severe in patients whose diabetes is poorly controlled 
(HbA1c > 7%). The term HbA1c refers to glycated hemoglobin, an index that clinicians use to 
measure average blood sugar levels over a certain time-period. The normal HbA1c level for a 
person without diabetes is 4 – 5.9%, for those who have diabetes, the target is around 6.5 – 7%, 
and for those at a greater risk of hypoglycemia, it is 7.5%. The goal of DSM is to improve the 
HbA1c control in individuals with diabetes and bring it closer to the optimal level (HbA1c ≤ 7). 
The American Association of Diabetes Educators (AADE) has summarized evidence-based 
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recommendations for DSM into the following behaviors: being active, eating healthy, taking 
medications, blood glucose monitoring, problem solving (particularly in patients with high or 
low blood glucose levels), reducing the risks for diabetes related complications and modifying 
psychosocial behaviors to adapt to living with diabetes. In addition, the American Diabetes 
Association (ADA) recommends weight loss or energy restriction, monitoring carbohydrate 
intake, high fiber intake, limitation of saturated fat, trans-fat, cholesterol, and sodium and lastly, 
consumption of fish twice a week. Diabetes care and management, and clinical preventive care 
practices such as annual eye exams, annual foot exams, daily monitoring of blood glucose, and 
diabetes self-management education (DSME), help control diabetes, thereby keeping people with 
diabetes healthy. The management of diabetes requires coordinated medical care coupled with 
patient self-management to decrease the risk of serious complications such as vascular, renal, 
and ophthalmologic morbidities.10 
Problem Statement 
According to the 2003-04 State of Diabetes in America Report, only 33% of the patients 
with diabetes achieved the American Association of Clinical Endocrinologists (AACE) 
glycosylated hemoglobin level (HbA1c) target of <6.5%.6  Moreover, the proportion of patients 
failing to achieve their target glucose levels appears to be rising. Patients who failed to achieve 
the ADA target of HbA1c <7% increased from 55.5% during 1988 - 1994 to 64.2% during 1999 
- 2000.2 It has been observed that these patients are likely to be non-responsive to their 
treatments. Strong evidences have linked uncontrolled HbA1c levels to increased risk of 
comorbidities such as diabetic neuropathy, retinopathy, CVD, and higher mortality rates.5 Failure 
to achieve glycemic control is attributed to various patient factors such as lack of knowledge, 
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comorbidities, financial resources (personal cost of care), non-compliance to therapy 
(adherence), as well as physician-related factors such as beliefs, attitudes, knowledge, 
communication with patients, type of health care system, and clinical inertia (inaction by 
physicians to initiate or intensify therapy when indicated).11-19 Despite advances in treatment 
options, an increasing number of patients fail to attain glycemic control. Evidence suggests that 
the lapse in treatment failure and therapy advancement could be a factor responsible for these 
unmet goals in disease management. Self-management of T2DM is a key element of the overall 
management of the disease.9  
Conceptual Framework 
 The overall study objective is to identify the barriers to self-management of diabetes in a 
primary care setting and addressing these barriers using a theoretical framework. This is a cross-
sectional study of patients with T2DM and their physicians in a primary care setting in 
Southwestern PA. The study employed a mixed method approach and combined the patient 
survey data with the patient’s information extracted from their physician’s EMR database. 
Responses from the patient survey were linked to different clinical outcomes available in the 
EMR database. The EMR database includes data from patient records including demographics and 
clinical diagnoses, procedures, laboratory test results, medication types and dosages, HbA1c levels, 
lipid profile, BMI, office visits, and comorbidities. Physicians were administered a survey to 
assess their perceptions of patient barriers and challenges in managing uncontrolled T2DM 
patients. This study aimed to identify the barriers and facilitators to diabetes self-management 
and determine the strength and direction of their predictive value over the metabolic control in 
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these patients.  The interrelationship of barriers and facilitators with each other were also 
assessed. 
Study Objectives 
Few studies exist on improving diabetes self-management among patients. In addition, 
views and practices of practitioners caring for these patients have received little attention.  Thus, 
the overall study objective is to identify the barriers to self-management of diabetes in a primary 
care setting and addressing these barriers using a theoretical framework.  
Specific aims 
Aim 1: To identify patient perceived barriers and facilitators to diabetes self-management.  
Aim 2: To assess patients’ readiness to change their diabetes self-management behavior. 
Aim 3: To identify physician perceived barriers to diabetes self-management. 
Aim 4: To explore physicians’ challenges to overcome the barriers to self-management. 
Following identification of physician and patient barriers and challenges to diabetes self-
management, a pharmacist-initiated individualized approach to these barriers will be 
conceptualized. 
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Research Questions and Overall Hypothesis 
Research Questions for Aim 1: 
One aim of this study was to identify the barriers and facilitators to diabetes self-management 
(DSM). Additionally, the objective was to explore which of these factors significantly predict 
DSM in the study population.  
Q1. Is there a relationship between HbA1c control and diabetes self-management questionnaire 
(DSMQ) score for the study population? 
 Hypothesis 1 – There is no association between HbA1c and DSMQ scores. 
Q2. Is there a relationship between various barriers and facilitators (factors) and HbA1c control? 
 Hypothesis 2 – There is no association between various factors and HbA1c control. 
Q3. Is there a relationship between various barriers and facilitators (factors) and DSMQ scores? 
 Hypothesis 3 – There is no association between various barriers and facilitators (factors) 
and DSMQ scores. 
Research Question for Aim 2: 
Another aim of this study was to identify the differences in patients’ characteristics based on 
their readiness to change their health behavior. 
Q4. Is there a relationship between patient’s readiness to change (as measured by their scores on 
the stages of change ruler) and their diabetes self-care behaviors such as DSM, knowledge, 
attitudes and beliefs related to diabetes, and their demographic characteristics? 
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 Hypothesis 4 – There is no association between patients’ readiness to change and their 
diabetes self-care behaviors such as DSM, knowledge, attitudes and beliefs about 
diabetes and their demographic characteristics. 
Research Question for Aim 3: 
Apart from assessing the patients’ perspectives about their diabetes self-care behaviors, the aim 
was also to assess their physicians’ perceptions about their practice and what prevented their 
patients from achieving optimal self-management. 
Q5. Which physician-related factors that affect DSM were significant? 
 Hypothesis 5 – No physician-related factors that affect DSM were found to be significant. 
Research Question for Aim 4: 
We aimed at exploring physicians’ challenges in improving their diabetes patients’ diabetes self–
management. 
Q6. Are there any recurrent themes that emerge from the physician reported challenges in 
addressing patient barriers? 
 Hypothesis 6 – No recurrent themes emerge from the physician reported challenges to 
address patient barriers. 
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Significance of the Study 
Identifying barriers and facilitators to self-management and addressing them is a critical 
step in achieving improved health outcomes in T2DM. Existing literature focuses mainly on 
patient factors and less so on physician factors or physician-patient interactions.20 A disconnect 
between the patients’ and physicians’ perceptions, knowledge, and attitudes can cause confusion 
and conflict, which may potentially lead to poor patient health outcomes.20 There is a need to 
explore the factors responsible for the patient’s non-responsiveness to their therapy. 
Additionally, better understanding of physician’s perceptions is needed to improve diabetes care 
and to promote self-management in this patient group.  
Another important factor that needs to be assessed during the identification of barriers 
and facilitators is the patient’s readiness to change their health behaviors. The Trans-Theoretical 
Model (TTM) of change assesses patients’ readiness to change their health behaviors, and 
measures the continual progression of individuals through a series of stages. These stages are 
pre-contemplation (not ready to change/ unaware of the problem), contemplation (realizing the 
existence of problem, weighing its pros and cons), preparation (intending to act in a near future), 
action (adopting new behaviors), and maintenance (sustaining new behavior to prevent 
relapse).21 It is important to recognize the degree to which patients are reluctant to change and 
then addressing their conviction systematically using a stepped care model. Interventions using 
the TTM framework in combination with other strategies have resulted in improved outcomes in 
previous studies. Another aspect of this model is ‘Self-Efficacy.’ As the patients progress 
through the various steps in the model, they become more confident and self-sufficient in 
managing their disease.21  
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This study is the first to explore both primary care physicians’ and patients’ perceptions 
about the barriers to self-management of T2DM in a primary care setting. Results from our 
systematic review of literature suggest that diabetes management can be achieved best in a 
primary care setting with an individualized approach to address the barriers to improved 
outcomes. These barriers include but are not limited to patient-related barriers such as adherence, 
attitudes and beliefs, knowledge, culture/ethnicity/language, financial resources, comorbidities, 
and social support. Health care provider factors such as beliefs, attitudes and knowledge, patient-
provider communication and interaction, and type of health care system were also identified as 
potential barriers. Assessment of these barriers is an essential step in developing interventions 
that are targeted at improving the health of patients with uncontrolled diabetes. Successful 
development and implementation of effective interventions such as regular monitoring and 
increased patient control on disease management can help improve their clinical outcomes as 
well as the overall quality of life. A large proportion of patients with controlled diabetes (HbA1c 
≤ 7%) will ensure reduction in the overall healthcare expenditure in diabetes as well. 
When patients are unable to reach their specified HbA1c goal, the ADA recommends 
several interventions. These may include intensifying the treatment regimen, identifying barriers 
to adherence, and increasing frequency of patient contact.22 Prior studies have reported 
improvements in patient’s glycemic control through pharmacist intervention. In particular, 
physician-pharmacist collaboration has been shown to significantly improve glycemic control in 
patients who did not reach their treatment goals with usual medical care.23 An intervention where 
a pharmacist follows-up on the patient's self-monitored goals and assists them in identifying and 
overcoming barriers can be implemented. Thus, the results from this study will serve as an 
important resource to design and implement targeted patient interventions that help improve the 
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health of the diabetes population and also enhance their quality of life. A follow-up to this study 
could be to employ a pharmacist-based intervention to address the identified barriers, following 
which a cost benefit analysis could be performed to examine whether the pharmacist-based 
intervention is an economically viable option that can be implemented on a large scale. 
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CHAPTER 2: REVIEW OF LITERATURE 
 Limited data exists on improving diabetes self-management among patients with T2DM. 
In addition, views and practices of primary care physicians caring for these patients have 
received little attention.  Thus, the overall study objective was to identify the barriers to self-
management of diabetes in a primary care setting from the perspective of both patients and 
physicians. 
Objectives of the Review 
 The goal of the review was to identify studies that have reported barriers and facilitators 
to self-management of T2DM from the perspectives of patients and healthcare providers such as 
physicians, nurse practitioners and/ or medical assistants, or both patients and healthcare 
providers.  The review also included studies that employed the Transtheoretical Model of 
Change (Stages of Change Model) in identifying barriers and facilitators of self-management. 
Further, articles exploring the relationship between these factors and self-management and/ or 
glycemic control using a structural equation modeling (SEM) framework were also examined.  
Methods 
Search Strategy 
A systematic literature search was conducted among peer-reviewed journals from year 
1990 to year 2014 across electronic databases such as PubMed, Scopus, Google Scholar, and 
CINAHL. The search was conducted in accordance with Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Figure 2.1). 
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Figure 2.1: Schematic Presentation of Methodology and Search Criteria 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Excluded Articles: n = 1500 
Studies that were 
interventions, T1DM related 
studies and studies unrelated 
to the topic of interest were 
excluded 
1615 full text articles were screened 
115 full text articles were reviewed 
Articles included for evaluation (n = 95):  
54 studies on barriers to self – management: 
Patients’ Perspectives 
9 studies on barriers to self – management: 
Physicians’ Perspectives 
19 studies on barriers to self – management: 
Patients’ & Physicians’ Perspectives 
2 studies on Stages of Chance model in 
assessing barriers to self – management 
4 studies employing SEM to explore 
relationships between various barriers/ 
facilitators to self – management 
Excluded Articles: 
11 studies did not focus on 
self-management 
9 studies did not focus on 
T2DM 
11,828 articles identified through database 
search: (PubMed (n = 4848), Google Scholar, 
Scopus (n = 2685), ProQuest (n = 3,474), 
Social Sciences Citation Index (n = 2019) and 
Cinahl (n = 1487) Excluded Articles: n = 
10,213 
Clinical trials, commentaries, 
reports were excluded 
Articles whose full text was 
unavailable were excluded 
Articles included for evaluation (n 
= 95): 
39 qualitative studies using focus 
groups 
32 survey based studies 
7 reviews 
2 studies with EMR 
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The search strategy included the following keywords and their combinations: Diabetes, 
type 2 diabetes, self–management, self–care, barriers, facilitators, factors, clinical inertia, 
stages of change, readiness to change, transtheoretical model of change.  The search was 
expanded by the identification of additional key search and MESH terms uncovered in the initial 
review. Some searching on other databases, such as ProQuest and Social Sciences Index was also 
fruitful, in identifying articles of interest. Bibliographies of identified articles were screened for 
additional studies of relevance that may have been cited.  The search was limited to studies 
published in the English language. However, the search was not limited by geographic location 
of the study population. 
The aim of this search was:  
1. To identify studies that assessed barriers and facilitators to diabetes self–management in 
patients with T2DM from the perspectives of patients and/ or their health care providers 
2. To explore studies that assessed health care providers’ challenges in addressing these 
barriers 
3. To evaluate studies that assessed changes in patient behavior based on the Stages of 
Change Model 
4. To identify studies that explored the relationships between various barriers and 
facilitators to self–management and glycemic control in patients with T2DM  
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Inclusion and Exclusion Criteria 
Articles were included in the final review if they explored the barriers and facilitators to 
DSM in T2DM population or explored the providers’ challenges in addressing these barriers. 
Articles that evaluated the self-management behavior of patients with T2DM using a theoretical 
framework were also included in the review. Studies focusing on T1DM or on interventions for 
improving the self–management in patients with T2DM were excluded from the final review. 
Randomized clinical trial studies that reported only clinical outcomes, articles that assessed non-
pharmacological treatments, psychometric studies, conference abstracts, dissertations, 
commentaries, editorials, or summary reports and review articles were excluded from the review. 
Data Extraction 
 After applying the inclusion/exclusion criteria, the identified studies were further 
subjected to extensive review in order to extract the relevant data. For studies assessing barriers 
and facilitators to diabetes self- management, the following information was collected: barriers/ 
facilitators/ factors assessed, study population (patients/ health care providers), sample size, 
socio-demographic variables (age, ethnicity and geographic location), study setting, methods and 
key findings. Studies describing the instruments utilized to measure these factors were evaluated 
for the type of scale utilized and their psychometric properties such as reliability and validity. 
Data regarding the relationships between various patient and physician related factors associated 
with diabetes self-management, using a SEM framework, was also collected. 
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Results of Literature Search 
1. Assessment of Barriers and Facilitators to Diabetes Self–Management: 
Self-management plays an important role in the overall management of diabetes. A 
number of psychological factors such as knowledge, adherence, readiness to change and 
medication preferences contribute to the overall self-care behaviors of patients with T2DM. 
Although knowledge of the disease is paramount in coping with the stress related to living with 
diabetes and effectively managing it, it is not sufficient to bring about behavior change regarding 
self-care management to achieve optimal glycemic control. Patient’s attitudes and beliefs also 
play a significant role in influencing their overall self-care behaviors. Other factors such as 
relational conflicts (disagreements or misperceptions in relations that lead to strong negative 
thoughts), lack of social support, financial barriers, and access to health care could influence 
patient’s self-management of diabetes. A deeper understanding of patient’s perspectives will 
assist health care professionals to recognize his/her specific needs and devise treatment plans to 
optimize the outcomes.24 
 The past two decades have seen a paradigm shift in the treatment of patients with 
diabetes. Surprisingly, this time period has also witnessed an increasing number of patients 
failing to achieve optimum glycemic control. These changes may have contributed to an 
increased incidence of diabetes complications over time. Evidence shows that optimum glycemic 
control can be achieved through early, aggressive management of diabetes.25 However, there are 
several challenges to diabetes management.  These include optimization of the use of treatment 
options to ensure adequate glycemic control, blood pressure management and lipid control, 
reducing the resulting complications, improving patient education on diabetes self-management 
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and patient adherence to pharmacologic and non-pharmacologic interventions, reducing barriers 
to insulin use and improving the delivery of health care.26 This review of literature focuses on 
various barriers and facilitators to diabetes self-management and self-care behaviors in patients 
with T2DM. 
Patients’ Perspectives on Factors Contributing to Diabetes Self-Management 
Seven standard self-management behaviors are identified by the American Association of 
Diabetes Educators: Healthy eating habits, active lifestyle, regular monitoring of blood glucose, 
medication adherence, problem solving for diabetes self-care related issues, healthy coping 
mechanisms and reducing the risk factors of acute and chronic complications. However, several 
barriers prevent the patients from performing these activities effectively. Identification of these 
barriers and development and implementation of realistic self-management strategies marked by 
collaborative alliances between patients and health care providers will ensure improved health 
outcomes in this population.27 This section highlights patients’ perspectives of these barriers and 
facilitators to diabetes self-management as elucidated in the literature search. 
Self-efficacy is an important characteristic that influences patients’ self-care behaviors in 
managing their diabetes. Rosenstock’s proposal of incorporating the attribute of self-efficacy of 
patients in an expanded health belief model was corroborated by a study, which found that the 
perceived barriers to self-efficacy were associated with poor self-care behaviors while a 
perception of self-efficacy was associated with better adherence to self-care activities and 
consequentially, improved outcomes.28A randomized control study evaluated the ‘superiority of 
assessment of barriers to self-care and strategies to cope with these barriers’ over ‘usual care 
with attention control’ in an elderly population with diabetes.29 It was found that diabetes-related 
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distress was lowered by providing attention alone, but focused strategies to cope with barriers 
employed by diabetes educators improved glycemic control and self-care frequency, and 
maintained functionality in addition to lowering distress in this population.   
 Self-monitoring of blood glucose (SMBG) is considered one of the major components of 
diabetes self-management since the results from Diabetes Control and Complications Trial 
demonstrated the efficacy of intense glycemic control through insulin therapy and SMBG in 
improving health outcomes.30 A study by Ong et al (2014) explored the barriers and facilitators 
to self-monitoring of blood glucose (SMBG) in patients with T2DM dependent on insulin 
through semi-structured individual in-depth interviews of 15 participants in Malaysia.31 
Frustration regarding high HbA1c levels, stigma, fear of needles and pain, costs of test strip and 
needles, inconvenience, unconducive workplace, and lack of motivation, knowledge and self-
efficacy were identified as barriers in the study. The identified facilitators to SMBG were: 
experiencing hypoglycemic symptoms; desire to see the effects of dietary changes; desire to 
please the physician; and family motivation. The authors concluded that the health care providers 
must take into account participant’s perceptions of the purpose of SMBG, the emotions 
associated with SMBG, and the complexity, pain, and cost related to SMBG as well as personal 
and family motivation, when counseling people with diabetes on SMBG. A cross-sectional study 
explored similar barriers to SMBG in adults with diabetes in a Health Maintenance Organization 
(HMO).32 They concluded that it is a difficult task to change the self-monitoring behavior of 
patients with greatest risk for poor outcomes such as the elderly, minorities and those with lower 
socioeconomic status. 
An analysis of patient perceptions of barriers and facilitating factors to disease self-
management was performed using 12 focus group interviews of 70 patients with T2DM and 
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hypertension in San Jose, Costa Rica and Tuxtla Gutierrez, Mexico.33 The analysis employed a 
Transtheoretical Model of Change framework, where various barriers/ facilitators and themes 
emerging from the focus groups were categorized into different stages of change namely pre-
contemplation, contemplation, preparation, action and maintenance. Another study explored the 
level of physical activity, barriers to physical activity and strategies employed to meet physical 
activity goals in patients with T2DM using a Transtheoretical Model of change framework. This 
study found out that patients who opted to work on physical activity participated in more general 
and specific physical activity and had a higher stage of change for physical activity.34  
Poor patient–healthcare provider relationship, inadequate education and psychosocial 
problems were some of the themes identified in a qualitative study by Zamzam et al whose goal 
was to assess barriers to diabetes control in Syrian women.35 The need to explore patient’s 
psychological barriers was pointed out by another study that assessed the relationship between 
depression, self-esteem, diabetes-care and self-care behaviors in a middle-aged Mexican 
population.36 Barriers to medication adherence were explored in a poorly controlled diabetes 
population by Odegard et al (2008) and they found that taking more than two doses of DM 
medication daily and difficulty reading the diabetes medication labels were two factors that had a 
significant association with higher HbA1c levels.37  
  The results from a study by Cox et al (2004) in low income African-American and 
Caucasian adults with T2DM showed that best disease management is possible in patients with 
high degree of knowledge of diabetes, positive attitudes, adherence to diet, and few perceived 
barriers to physical activity.  They also found that similar educational strategies can be 
implemented effectively for patients with T2DM belonging to both races.38 However, another 
study by Lynch et al (2012) focusing on racial differences between African American and 
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Mexican American low income T2DM patients pointed out that several differences exist between 
these races with respect to diabetes self-management and that an understanding of these 
differences may facilitate development of effective self-management interventions in these high 
risk populations.39 The need for improving diabetes self-management knowledge is also 
underscored by a cross-sectional survey based study of 30 Puerto Rican adults with T2DM.40  
A qualitative survey based study by Zgibor and Simmons (2002) explored the barriers to 
blood glucose monitoring (BGM) in a multiethnic community.41 Following categories of barriers 
to diabetes care were generated: Internal psychological (self-efficacy/health beliefs), external 
psychological (psychosocial environment), internal physical (comorbidities/side effects of 
treatment), external physical (finance/access to care) and educational (knowledge of 
diabetes/services) barriers. The findings indicated that patients reporting both internal and 
external psychological barriers and external physical barriers were unsuccessful at performing 
BGM irrespective of their age, ethnicity, insulin use, sex, diabetes knowledge, and glycemic 
control. 
 Depression is associated with a higher number of barriers to self-management in patients 
with T2DM. This underscores the importance of depression screening and depression treatment 
in these patients.42 Another important factor identified by Tiedt et al in a Native American 
population was perceived unsatisfactory care, which served as a barrier to self-management. 
Other barriers to self-management in this population were communication barriers (distrust, 
misunderstanding, and educational methods) and organizational barriers (quality of care and 
access issues).43  Interventions addressing these barriers should have cultural relevance and 
incorporate family support and diabetes self-management skills education.44 Good social support 
is a significant indicator of health promoting activities and overall well-being among patients 
 22 
with T2DM.45 Family support can play an important role in improving self-efficacy of patients 
with diabetes and thus, improve their overall self-management adherence. On the other hand, 
non-supportive behaviors by family members can influence the patients’ self-management 
adherence negatively.46  
In a study by Strauss et al (2006), driving distance was identified as an important barrier 
to glycemic control in a population comprising of older, rural individuals.47 In patients whose 
diabetes is resistant to the standard diabetes care and who persistently exhibit poor glycemic 
control, strategies should selectively target those barriers responsible for this resistance.48, 49  
Health Care Provider’s Perspectives on Factors Contributing to Diabetes Self-Management 
 A few studies have reported health care providers’ perspectives regarding self-
management in their patients with diabetes. A study by Scrambler and colleagues utilized in-
depth semi-structured interviews to explore health care professional’s opinions about the 
opportunities and barriers in empowering patients with T2DM. The result showed that 
empowerment of patients is beneficial for both, patients and Health Care Practitioners (HCPs). 
However, there are some important barriers such as lack of resources, time and HCPs’ training in 
patient empowerment, which the HCPs face in the clinical implementation of empowerment on a 
daily basis. In patients who remain uncontrolled in a primary care setting, it has been suggested 
that directing the patients to an endocrinologist or diabetes educators who focus on addressing 
barriers to improving glycemic control may produce positive results.50 This can be achieved 
through improved patient engagement. Intrinsic factors such as attitudes and health beliefs, 
depression, self-efficacy, level of diabetes knowledge and technical skill, ethnic perspectives, 
functional health literacy and medication adherence, impact patient engagement. In addition, 
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patient engagement is affected by extrinsic factors such as financial capabilities, family 
influences, workplace environment, community environment, clinical relationships and access to 
effective diabetes healthcare delivery. 
 Carratala-Munuera and colleagues used Delphi technique to draw consensus between the 
opinions of health care experts of T2DM on a 41-item questionnaire that explored barriers 
associated with poor glycemic control in a Spanish population with diabetes.51 The study found 
that non-compliance to therapy improved with a well-informed partner/ family/ caregiver, patient 
education, motivation and the health care provider’s ability to share and agree on decisions with 
the patients. Clinical Inertia, described as the lack of treatment intensification in a patient not at 
evidence-based goals for care, was found to improve with motivation and education of the health 
care professionals. It gets worse with lack of consultation time, missing data in medical records, 
misinterpreting border high readings as normal, lack of treatment goals and teamwork between 
physicians and nurse, scarcity of resources, and lack of alarm systems or flags in the EMR on 
potential goals. The consensus was that interventions should focus on non-therapeutic 
compliance and clinical inertia in order to improve glycemic control in patients with T2DM. 
 The need for continuous diabetes education for patients and healthcare professionals was 
emphasized in a study by Sprague et al (2013), which assessed diabetes educators’ perspectives 
on barriers affecting patient access to and utilization of diabetes education and its utilization.52 A 
qualitative analysis of 25 Delaware physicians identified the following barriers to diabetes 
management: a persistent orientation towards acute care, lack of patient based proactive patient 
management, insufficient diabetes self-management education, poor integration of payer-driven 
disease management activities, lack of available clinical information and public health support. 
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These findings suggest that barriers like these limit the ability of primary care providers to 
manage their patients with T2DM.53  
Patient’s and Health care provider’s perspectives on Factors Contributing to Diabetes Self-
Management 
A comprehensive assessment of patient barriers from both patient’s and physician’s 
perspectives may aid in designing specific, measurable, achievable, relevant and time-bound 
(SMART) interventions to address these barriers. The literature review yielded the following 
studies that took into account both these perspectives. Nam et al (2011) published a review on 
barriers to diabetes management with an objective of exploring both patient and provider 
factors.20 They summarized the following patient factors that could affect self-management: 
Adherence, attitudes and beliefs, knowledge of diabetes, culture and language capabilities, health 
beliefs, health literacy, financial resources, co-morbidities and social support. They also 
identified the following provider factors: Attitudes, beliefs and knowledge of diabetes and 
patient- physician communication. Another review of barriers to self-management of diabetes by 
Ahola et al (2012) observed knowledge, empowerment, health literacy, health beliefs, self-
efficacy, coping, problem solving skills, locus of control, depression, fear of hypoglycemia, and 
social support as the major patient barriers while physician-patient communication and 
physician’s knowledge, beliefs and attitudes were noted as provider barriers.15  
Shultz et al (2001) assessed the views of patients with T2DM and their diabetes educators 
regarding barriers to diet and exercise, which are two of the essential components of diabetes 
self-management.52 They employed cross–sectional mail survey design to gather information 
from patients (n = 97) from three small regional hospitals from eastern Washington and diabetes 
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educators (n = 147) from the Washington Association of Diabetes Educator (WADE). The 
results indicated a difference in patients’ and diabetes educators’ perceptions regarding these 
barriers, suggesting the need for focusing on barriers that may be specific to a given patient, 
thereby providing an individualized approach to care. Beverly et al (2012) explored physicians’ 
and patients withT2DM’s views on their perceived responsibility and self-blame regarding 
patients’ difficulty in achieving diabetes treatment goals.16 It was a qualitative study that 
employed in-depth interviews with a semi-structured interview guide, of 19 endocrinologists and 
primary care physicians and 34 patients with diagnosed T2DM. Physicians were reported to 
accept responsibility for patients not achieving treatment goals and felt like they may not be 
doing enough to help their patients. On the other hand, patients blamed themselves for not being 
able to achieve the recommended goals. Both physicians and patients perceived that the other felt 
frustrated and disappointed regarding unmet goals. The authors concluded that these factors may 
act as barriers to an effective relationship between physicians and patients. A better 
understanding of each other’s frustrations and challenges in management of diabetes may result 
in improved outcomes in these patients and increased satisfaction in their physicians.  
A total of 13 themes of barriers and facilitators to T2DM emerged in a study by Jones et 
al (2013) who employed a cross-sectional qualitative study design through focus group (n = 8) 
and telephone interviews of patients (n = 10), and telephone interviews with health professionals 
(n = 18).  These themes include interpersonal (stress and relationships), organizational (access to 
recommended foods, transport, health professional, and exercise options) and societal 
(engagement and social attitudes).54 Overall, the participants found it difficult to maintain 
preferred management behaviors.  
 26 
A study by Renfrew et al (2013) conducted in Cambodia utilized focus group interviews 
of health care providers, staff and patients with diabetes.55 The authors reported that certain 
cultural beliefs, low health literacy, and language barriers strongly affected Cambodian patients’ 
understanding of diabetes and self- management, as well as clinicians’ ability to care effectively 
for Cambodian patients with diabetes. Focus group interviews of 15 physicians and 37 patients 
with T2DM conducted by Carbone et al (2006) assessed the physicians’ perceptions of patient 
knowledge, attitudes and behaviors. Patient knowledge, beliefs, practices, barriers and 
facilitators were also assessed.56 Findings indicated that the patients frequently had negative 
thoughts about self-management while their religious beliefs and support of the practitioners 
positively affected their self-management behaviors.   
Wu et al (2014) examined the differences in perceptions of self-care, health education 
barriers and educational needs between patients with DM and their nurses.57 A cross-sectional 
survey based design was utilized in a convenience sample of 312 patients with T2DM and 202 
nurses. The patients perceived that they performed self-care activities successfully while the 
nurses perceived the patients to be inefficient in performing these tasks. The need for diabetes 
education was highlighted by nurses more than patients and the nurses also perceived that the 
patients my experience difficulties in diabetes health education more than the patients themselves 
perceived.  
A study by Piette et al (2003) highlighted the importance of patient physician 
communication in improving diabetes self-management.58 Simmons et al (2007) found that 
discordance exists in the perceptions of patients and healthcare professionals regarding the 
importance of different barriers to diabetes care.12  
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A multinational Diabetes Attitudes, Wishes and Needs (DAWN) study assessed the 
psychological problems and barriers to improved diabetes management from healthcare provider 
and patient perspective.59 Patients were found to rate themselves better at self-care activities in 
comparison to their physicians. Most patients were found to have poor psychological well-being 
as reported by the healthcare providers. Providers often lack the critical resources such as skill, 
time and adequate referral sources to improve diabetes management through addressing these 
barriers. The results from a South African study emphasized the need for patient-centered 
approach to care in enhancing their knowledge of the disease and encouraging change in health 
behaviors. 
Summary 
The articles in this review focused on several patient related factors that influence 
diabetes self-management and glycemic control. Facilitators such as improved self-efficacy and 
adherence, regular self-monitoring of blood glucose, positive attitudes, adherence to diet and 
physical activity and family support and social support were identified. Barriers such as lack of 
knowledge and motivation, frustration, stigma, poor physician – patient relationship and 
comorbidities such as depression were also identified. The relationships between these factors 
and diabetes self-management were explored using different tools such as focus groups and 
semi-structured interviews. Health Belief Model and Transtheoretical Model of Change were 
also employed in assessment of these relationships.  In addition to the patient factors, several 
physician-related factors were identified in the review, which included barriers such as lack of 
time, resources and proper training of HCPs to empower patients, lack of motivation, poor 
physician-patient relationship and clinical inertia. The findings of this review underscore the 
need for a comprehensive assessment of the overall factors that influence/ affect diabetes self-
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management and glycemic control. Doing so will enable health care practitioners to design and 
implement targeted interventions to improve health outcomes in patients with T2DM. 
2. Instruments assessing various Barriers to self-management: 
This section discusses various instruments assessing diabetes self-management or related 
self-care activities that were identified in the literature review.  Van Dijk-de Vries et al (2011) 
developed ‘Health Promotion Diabetes’ (HEPRODIA) instrument to identify the needs of 
patients with diabetes mellitus for activities that promote health through preferred change in their 
lifestyle behavior.60 The study by Mollem et al (1996) attempted to assess perceived barriers to 
self-care in insulin-dependent diabetes patients using Barriers in Diabetes Questionnaire 
(BDQ).24 This instrument can serve as a valuable and reliable tool to find focus points for patient 
education in different populations. On an individual level, BDQ can help explore patient’s 
specific problems such as difficulty in injecting insulin at regular intervals before meals, 
controlling the blood glucose levels, managing dietary requirements, and attitudes towards these 
behaviors. Lin et al (2007) developed Diabetes Self-Management Instrument (DSMI) to measure 
self-management of adults with T2DM.61 Cox ED et al developed and validated PRISM 
(Problem Recognition in Illness Self-Management); an instrument that assesses barriers to self-
management in adolescents with DM.62 Factor analysis of the instrument identified the following 
domains: Understanding and Organizing Care, Regimen Pain and Bother, Denial of Disease and 
Consequences, and Healthcare Team, Family, or Peer Interactions. All these domains were found 
to be significantly related to HbA1c. Another instrument, Diabetes Self-Management 
Assessment Report Tool (D-SMART) collects information about patients’ behaviors and 
identifies their priorities and barriers to change, thus providing valuable inputs for diabetes self-
management education (DSME). Abubakari et al (2011) assessed the factor structure and internal 
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consistency of the Revised Illness Perception Questionnaire (IPQ-R) in a population with T2DM 
and found its psychometric properties satisfactory.63 A modified 34-item model of IPQ-R by 
Brzoska et al (2012) showed good reliability and validity in in assessment of illness perception in 
a Turkish healthcare setting.64 Diabetes Self-Management Questionnaire (DSMQ) was designed 
by Schmitt et al (2013) to assess the self-care activities that can predict glycemic control in 
patients with DM.65 It demonstrated acceptable psychometric properties and has value in 
scientific analyses as well as clinical use for this population. The Patient perceived Difficulty in 
Diabetes Treatment (PDDT) scale is a 12-item questionnaire developed by Tamir et al (2012) 
that measures the following characteristics: adherence to self-monitoring of glucose schedule, 
frequency of self-monitoring of glucose, adherence to medication administration schedule, 
frequency of medication administration, multiple number of medications, synchronization 
between meals and medications, dependence on the medications, pain associated with treatment, 
diet restrictions, self-care, multiple healthcare providers, and costs of treatment.66 This 
instrument is a resource in identifying the potential barriers to adherence to treatment guidelines 
and new treatment options. A 28-item Diabetes, Hypertension and Hyperlipidemia (DHL) 
knowledge instrument assesses the knowledge of patients regarding these diseases and 
medications.67 This instrument can be used to test the baseline patient knowledge of these 
diseases and/ or determine the effectiveness of an educational intervention.  
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Table 2.1: Instruments Assessing Barriers and Facilitators to Diabetes Self-Management 
Abbreviation Instrument Items Domains Domain Description Scaling and 
Scoring 
Administrati
on 
Psychometric 
Properties 
HEPRODIA Health Promotion 
Diabetes 
14 
fixed 
4 – 20 
variabl
e 
2 Intention to change 
health care behavior, 
Self-efficacy and needs 
for support to 
overcome obstacles (in 
smoking cessation, 
dietary behavior, 
physical activity and 
other health promoting 
activities) 
5 point 
Likert scale 
(Strongly 
disagree to 
strongly 
agree) 
Patients Reliability: 
Cronbach’s α 
= 0.46 to 0.74 
Validity: Face 
validity 
BDQ Barriers in Diabetes 
Questionnaire 
28 3 NA 5 point 
Likert scale 
(very good 
– very bad) 
Patients Reliability: 
Cronbach’s α 
= 0.73 
Validity: 
Unknown 
DSMI Diabetes Self-
Management 
Instrument 
35 5 Self-integration, self-
regulation, interaction 
with health 
professionals and 
significant others, self-
monitoring of blood 
glucose, adherence to 
recommended regimen 
4 point 
Likert scale 
(not relevant 
to very 
relevant) 
Patients Reliability: 
Cronbach’s α 
= 0.94 
PRISM Problem Recognition in 
Illness Self-
Management 
32 6 Understanding and 
Organizing Care, 
Regimen Pain and 
Bother, Denial of 
Disease and 
5 point 
Likert scale 
(Strongly 
disagree to 
Patients Reliability: 
Unknown 
Validity: 
Construct, 
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Consequences, and  
Healthcare Team, 
Family Interactions, 
Peer Interactions 
strongly 
agree) 
Discriminant, 
Concurrent 
PDQ Personal Diabetes 
Questionnaire 
68 13 Perceived blood 
glucose control, Weight 
change readiness, Diet 
knowledge and skills, 
Diet change readiness, 
Diet decision making, 
Eating problems, Diet 
barriers, Medication 
use, Medication 
Barriers, Blood glucose 
monitoring, Blood 
glucose monitoring 
barriers, Physical 
activity, Exercise 
barriers 
Variable 
scaling and 
scoring for 
each domain 
Patients  Reliability: 
Cronbach’s α 
= 0.650 – 
0.834 
Validity: 
Critetion 
 
D-SMART Diabetes Self-
Management 
Assessment Report 
Tool 
- - - - Patients Reliability: 
Test-Retest, 
Inter item 
consistency 
Validity: 
Face, Content, 
Concurrent 
IPQ-R Revised Illness 
Perception 
Questionnaire 
34 3 Psychological causes, 
Biological risk factor 
causes, External/ other 
causes. 
5 point 
Likert Scale 
(Strongly 
agree to 
Patients Reliability: 
Cronbach’s α 
> 0.61 for 
each subscale 
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strongly 
disagree) 
Validity: 
Factorial, 
discriminant 
DSMQ Diabetes Self-
Management 
Questionnaire 
16 5 Glucose management, 
Dietary control, 
Physical activity, 
Healthcare use and 
Sum scale 
4 point 
Likert Scale 
(Applies to 
me very 
much – does 
not apply to 
me) 
Patients Reliability: 
Cronbach’s α 
> 0.6 
Validity: 
Factorial,  
known group, 
convergent  
PDDT Patient perceived 
Difficulty in Diabetes 
Treatment scale 
12 1 NA 5 point 
Likert Scale 
(Not 
difficult at 
all – very 
difficult) 
Patients Validity: 
construct, 
discriminant 
DHL Diabetes, Hypertension 
and Hyperlipidemia 
Knowledge Instrument 
28 5 Diabetes, 
Hypertension, 
Hyperlipidemia, 
Medications and 
General issues 
True or 
False, 
Scoring 
from 0 – 28, 
converted to 
percentage 
Patients Reliability: 
Cronbach’s α 
= 0.79 
Validity: 
Content, 
Discriminant 
Abbreviations -  HEPRODIA:  Health Promotion Diabetes, BDQ: Barriers in Diabetes Questionnaire, DSMI: Diabetes Self-Management Instrument, PRISM: 
Problem Recognition in Illness Self-Management, PDQ: Personal Diabetes Questionnaire, D-SMART: Diabetes Self-Management Assessment Report Tool, 
IPQ-R: Revised Illness Perception Questionnaire, DSMQ: Diabetes Self-Management Questionnaire, PDDT: Patient perceived Difficulty in Diabetes Treatment 
scale, DHL: Diabetes, Hypertension and Hyperlipidemia Knowledge Instrument
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CHAPTER 3: METHODOLOGY 
The objective of this study was to understand the perspectives of patients with T2DM and 
their physicians regarding the barriers and facilitators to diabetes self-management. Prior 
research has focused on patient- and physician-related factors separately. However, this study 
was conceptualized to gain a comprehensive understanding of the perceptions of patients as well 
as their physicians in a primary care setting, using a theoretical framework. 
This chapter encompasses information on the research design, sampling methodology, 
data collection and statistical analyses. 
Research Design 
The study utilized a cross-sectional design and was conducted in two groups – physicians 
working in the Preferred Primary Care Physicians (PPCP) group (n = 39) and patients with 
T2DM who maintained an active status in the PPCP database.  A mixed method approach was 
utilized in patients with T2DM and a combination of survey research and electronic medical 
record (EMR) database analysis were used to identify barriers and facilitators to self-
management of T2DM.  Responses from the patient survey were linked to selected clinical 
outcomes available in the EMR database, which was useful in gaining additional information on 
patients, and also validating some of the self-reported patient information from the patient 
surveys. For the physician group, survey research was utilized to understand their perceptions of 
patient barriers, and challenges they encounter in managing patients with uncontrolled T2DM. 
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Data Sources 
Electronic Medical Records (EMR) Database 
An electronic medical record (EMR) can be defined as ‘a digital version of a paper chart 
that contains all of a patient’s medical history from one practice’.68 An EMR is essentially an 
electronic database for healthcare, with data recorded, developed, maintained, and/ or provided 
by clinicians and providers in direct patient care (diagnosis and treatment). EMR offers several 
advantages over paper based records, in that they allow the providers to track patient data over 
time, help them identify patients who require screening and other preventive visits, help monitor 
patients for parameters such as vaccinations or blood pressure readings, and finally help improve 
the quality of care provided in their practice.68 Adoption of EMR has been initiated by several 
integrated health providers in the US, such as Kaiser Permanente, Harvard Pilgrim Health 
System, and the Department of Veteran Affairs. EMR captures important clinical information 
from each patient visit and thus, enables measurement of clinical outcomes and resource 
utilization for each patient. Bates et al. argued in favor of implementation of EMR in primary 
care setting; they believed that primary care is at the center of all medical care and that providing 
excellent primary care demands that providers have all the necessary information while 
providing care.69 This information and all the decision support needs, they argued, can be made 
available through EMRs. The vision statement of the National Alliance for Primary Care 
Informatics reads: 
“To provide all U.S. citizens with good quality, affordable health care, every primary 
care provider must be given the opportunity of using an electronic ambulatory information 
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system, including a fully functional electronic medical record and with ability to access needed 
clinical information at the time and place of care.”69  
 The management of diabetes requires coordinated medical care coupled with patient self-
management to decrease the risk of serious complications such as vascular, renal, and 
ophthalmologic morbidities. Our study focused on identifying the factors (barriers and 
facilitators) that are associated with diabetes self-management in a primary care setting. In 
addition to the self-management related behaviors of the patients, it was also of interest to 
measure their clinical outcomes, and examine any association these outcomes may have with the 
patient’s level of self-management. Clinical data was pulled from the GE Centricity EMR 
database utilized by PPCP group. The database contains data from 2010-2014 of over 7,000 
active patients receiving care from 39 primary care providers in Southwestern Pennsylvania. The 
EMR data constitutes longitudinal patient data that includes patient demographics and clinical 
diagnosis, prescribed medications, procedures and laboratory tests. The PPCP group provided the 
required data from EMR for the purpose of study analysis. 
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Patients 
Identification of Patient Sample 
Patients were identified from the EMR database of the PPCP group. Patients >18 years, 
having 2 or more visits to their physicians (01/01/2012 to 12/31/2013) with a recorded diagnosis 
of T2DM (ICD-9-CM: 250.xx) were identified in the EMR database. From the EMR sampling 
frame of 7,000+ adult patients with T2DM, a random stratified sample of 2,100 patients was 
drawn. The stratification technique involved creating three different strata of patients based on 
their HbA1c levels: ‘Well Controlled’ (HbA1c < 7), ‘Moderately Uncontrolled’ (7 < HbA1c > 9) 
and ‘Severely Uncontrolled’ (HbA1c > 9), and then randomly choosing 700 patients from each 
strata. We retrieved information such as the patient names, addresses, and patient unique ID for 
our mailing purposes from the PPCP office. All patient records were assigned unique patient IDs, 
which were utilized to link the patient survey responses to the patient records in the EMR 
database so as to extract selected clinical information such as comorbidity, HbA1c, LDL, and 
diabetes medications. To ensure anonymity of the respondents, each patient in the sample was 
assigned a unique code corresponding to the patient’s unique ID before mailing out the surveys. 
All the identifying information such as patient name, address, and unique ID were deleted after 
mailing out the surveys. EMR data was extracted by PPCP group for those patients who 
responded to the surveys (n = 210).  
Patient Survey 
 The patient survey was designed to collect information about the patients’ demographic 
characteristics, their knowledge of diabetes, attitudes and health beliefs, level of self-
management, and their readiness to change health related behaviors. Standardized instruments 
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with acceptable psychometric properties were employed to collect this information. These 
instruments include Diabetes Self-Management Questionnaire (DSMQ) to measure DSM related 
behavior, Revised Illness Perception Questionnaire (IPQ -R) to measure attitudes and beliefs 
towards diabetes, Readiness to Change Ruler to assess their willingness to change health related 
behavior, and Medication Preference Scale to identify patient preference for oral medications 
and insulin. In addition, clinical information such as the patient’s most recent HbA1c level was 
also collected through the patient survey.   
Description of Patient Survey Instruments 
 The standardized instruments included in the patient survey are summarized below. 
These instruments were selected as they demonstrated acceptable psychometric properties 
(reliability and validity) and measured the variables of interest. Permission for use of these 
instruments in this study was sought and received from the authors of the respective instruments. 
1. Diabetes Self-Management Questionnaire (DSMQ) 
Diabetes Self-Management Questionnaire (DSMQ) is a 16-item questionnaire that 
assesses the level of self-management in patients with T2DM. It consists of the following 
subscales: ‘Glucose Management’ (GM: items 1, 4 6, 10 and 12), ‘Dietary Control’ (DC: items 
2, 5, 9 and 13), ‘Physical Activity’ (PA: items 8, 11 and 15), and ‘Health-Care Use’ (HU: items 
3, 7 and 14), as well as a ‘Sum Scale’ (SS: item 16) as a global measure of self-care. The 
questionnaire consists of some items that are worded negatively to minimize respondent bias. 
Higher score represents more effective self-care. The scale scores are calculated by summing the 
individual item scores and transforming it to a scale ranging from 0 to 10 (raw score/ theoretical 
maximum score * 10). (Refer Table 3.1) 
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2. Diabetes Instrument 
The diabetes subsection of the Diabetes, Hypertension and Hyperlipidemia (DHL) 
instrument was utilized to assess the patient knowledge of diabetes. It consists of 10 questions 
with true or false type response. Each correct answer gives 1 point to the respondent and a wrong 
answer gives 0 point. A higher score indicates higher diabetes knowledge. (Refer Table 3.2) 
3. Revised Illness Perception Questionnaire (IPQ–R) 
IPQ-R is a 34-item questionnaire that assesses the attitudes and health beliefs of patients 
with T2DM. The questionnaire consists of a 5-point Likert scale type response with 1 being 
‘strongly agree’ while 5 being ‘strongly disagree’. The following domains are identified in IPQ-
R: Timeline (acute/ chronic), Consequences, Personal control, Treatment control, Illness 
coherence, Timeline cyclical, and Emotional representations. Some items are negatively worded 
to minimize respondent bias (Refer Table 3.3).  
4. Readiness to Change Ruler 
The Readiness to Change Ruler is a 5-point Likert scale that assesses the patients’ 
willingness to change their health related behaviors. The scoring on this ruler is based on the 
Stages of Change Model. A score of ‘1 = Pre-contemplation (I do not think about changing my 
diabetes self-management behavior)’, ‘2 = Contemplation (I think about changing my diabetes 
self-management behavior)’, ‘3 = Preparation (I have decided to change my diabetes self-
management behavior)’, ‘4 = Action (I am already trying to change my diabetes self-
management behavior)’ and ‘5 = Maintenance (my diabetes self-management behavior has 
changed. I manage my diabetes efficiently)’. (Refer Figure 3.1) 
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5. Medication Preference Scale 
This scale gathers information about the patients’ preferences for medications. It’s a 2-
item, 10-point Likert scale seeking preference for insulin and other injectable preparations as 
well as for oral hypoglycemic agents, with responses ranging from 1: ‘not willing at all’ to 10: 
‘totally willing’. (Refer Figure 3.2) 
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Table 3.1: Diabetes Self-Management Questionnaire (DSMQ) 
Sr
. 
N
o. 
INSTRUCTIONS: The following statements describe 
self-care activities related to your diabetes. Thinking 
about your self-care over the last 8 weeks, please 
specify the extent to which each statement applies to 
you. Please answer the questions carefully. All 
responses will be kept confidential. 
(3) 
Applie
s to me 
very 
much 
(2) 
Applie
s to me 
to a 
consid
erable 
degree 
(1) 
Applie
s to me 
to 
some 
degree 
(0) 
Does 
not 
apply 
to me 
1. I check my blood sugar levels with care and attention 
 Blood sugar measurement is not required as a 
part of my treatment 
        
2. The food I choose to eat makes it easy to achieve 
optimal blood sugar levels 
        
3. I keep all doctors’ appointments recommended for my 
diabetes treatment 
        
4. I take my diabetes medication (e.g. insulin, tablets) as 
prescribed 
 Diabetes medication/ insulin is not required as 
a part of my treatment 
        
5. Occasionally I eat lots of sweets or the other foods 
rich in carbohydrates 
        
6. I record my blood sugar levels regularly (or analyze 
the value chart with my blood glucose meter) 
 Blood sugar measurement is not required as a 
part of my treatment 
        
7. I tend to avoid diabetes-related doctors’ appointments         
8. I do regular physical activity to achieve optimal blood 
sugar levels 
        
9. I strictly follow the dietary recommendations given 
by my doctor or diabetes specialist 
        
10
. 
I do not check my blood sugar levels frequently 
enough as would be required to achieve  good blood 
glucose control 
 Blood sugar measurement is not required as 
part of my treatment 
        
11
. 
I avoid physical activity, although it would improve 
my diabetes 
        
12
. 
I tend to forget to take or skip my diabetes medication 
(e.g. insulin, tablets) 
 Diabetes medication/ insulin is not required as 
a part of my treatment 
        
13
. 
Sometimes I have real ‘food binges’ (not triggered by 
hypoglycemia) 
        
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14
. 
Regarding my diabetes care, I should see my medical 
practitioner(s) more often 
        
15
. 
I tend to skip planned physical activity         
16
. 
My diabetes self-care is poor         
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Table 3.2: Diabetes, Hypertension and Dyslipidemia (DHL) Questionnaire 
Item Question True False 
1. Diabetes occurs in people with insufficient or no 
insulin 
    
2. As long as a diabetic person’s fasting blood sugar 
level in the morning is in the normal range, he/she 
can eat anything for that day 
    
3. Diabetes can be cured after taking medicines for a 
period of time 
    
4. If the blood sugar level is high for long period of 
time, it may cause other health problems such as 
blindness 
    
5. Normal fasting blood sugar is between 70-130 mg/dL     
6. There is no problem for our blood pressure to remain 
high as long as we do not feel sick 
    
7. Blood pressure of 140/90 mmHg and above is 
considered as high 
    
8. If not treated, high blood pressure can lead to kidney 
damage 
    
9. We can feel whether our blood pressure is high or not     
10. Diabetic people can eat as much fruits (such as 
banana, papaya, orange, water melon) as they like 
    
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Table 3.3: Revised Illness Perception Questionnaire (IPQ-R) 
Sr. 
No. 
Question Response 
  Strongly 
Agree 
 Strongly 
Disagree 
1. My illness will last a short time 1 2 3 4 5 
2. My illness is likely to be permanent rather than temporary 1 2 3 4 5 
3. My illness will last a long time 1 2 3 4 5 
4. This illness will pass quickly 1 2 3 4 5 
5. I expect to have this illness for the rest of my life 1 2 3 4 5 
6. My illness will improve in time 1 2 3 4 5 
7. My illness is a serious condition 1 2 3 4 5 
8. My illness has major consequences on my life 1 2 3 4 5 
9. My illness does not have much effect on my life 1 2 3 4 5 
10. My illness strongly affects the way other see me 1 2 3 4 5 
11. My illness has serious financial consequences 1 2 3 4 5 
12. My illness causes difficulties for those who are close to me 1 2 3 4 5 
13. There is a lot I can do to control my illness 1 2 3 4 5 
14. What I do can determine whether my illness gets better or 
worse 
1 2 3 4 5 
15. The course of my illness depends on me 1 2 3 4 5 
16. Nothing I do will affect my illness 1 2 3 4 5 
17. I have the power to influence my illness 1 2 3 4 5 
18. The negative effects of my illness can be prevented by my 
treatment 
1 2 3 4 5 
19. Treatment can control my illness 1 2 3 4 5 
20. There is nothing that can help my illness 1 2 3 4 5 
21. The symptoms of my illness are puzzling to me 1 2 3 4 5 
22. My illness has no meaning to me 1 2 3 4 5 
23. I don’t understand my illness 1 2 3 4 5 
24. My illness doesn’t make any sense to me 1 2 3 4 5 
25. I have a clear picture or understanding of my illness 1 2 3 4 5 
26. The symptoms of my illness change from day to day 1 2 3 4 5 
27. My symptoms come and go in cycles 1 2 3 4 5 
28. I go through cycles in which my illness gets better and worse 1 2 3 4 5 
29. I get depressed when I think about my illness 1 2 3 4 5 
30. When I think about my illness I get upset 1 2 3 4 5 
31 My illness makes me feel angry 1 2 3 4 5 
32. My illness does not worry me 1 2 3 4 5 
33. My illness makes me feel anxious 1 2 3 4 5 
34. My illness makes me feel afraid 1 2 3 4 5 
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Figure 3.1: Readiness to Change Ruler 
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Figure 3.2: Medication Preference Scale: 
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Patient Survey Administration 
 A mail survey was utilized for collecting patient data. In accordance with the Health 
Insurance Portability and Accountability Act (HIPAA), patients were mailed a consent form at 
the time of study enrollment informing them of the use of their medical information for research 
purposes and requesting their voluntary participation. The participants were also mailed a cover 
letter describing the study, the questionnaires, and a self-addressed reply envelope. The survey 
administration was conceptualized in accordance with the Dillman Total Design Survey Method, 
which requires the survey population to be administered with the questionnaire booklet, which 
should be fewer than 12 pages.70 The Dillman method requires four mailings (including a follow-
up post card) and a non-response survey for those who did not respond to any of the mailings.  
Due to financial constraints (cost of survey and mailing charges), this study utilized a one-time 
mailing. A nonresponse analysis was conducted by comparing early to late responders since 
research has shown that late responders have characteristics similar to non-responders.  In this 
study, the initial surveys were sent out in accordance with the Dillman Method but due to limited 
funding, follow up surveys and reminder post cards were not mailed. However, the responses 
received from the single mailing were enough to be able to conduct the proposed analyses. 
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Patient Variables Extracted from Survey Report and EMR Database 
Age  
Age was reported by the participants through the surveys. It was measured in years and 
categorized as 18 – 40 years, 41 – 50 years, 51 – 60 years, 61 – 70 years and ≥ 71 years. The 
survey reported age was validated from the age variable found in the EMR database. 
Gender  
The gender variable was used as the indicator of sex. This variable was also validated using the 
EMR database. 
Ethnicity  
For the purpose of analysis, this variable was categorized as Caucasian, African-American, 
Asian, Hispanic and Others. This variable was also reported in the EMR database. 
Education (survey reported) 
This variable records the educational status of the participants in the following groups: less than 
high school, high school/ vocational/ technical/ G. E. D. (General Educational Development), 
some college, college and graduate. 
Marital Status (survey reported) 
This variable measured the marital status of the participants as currently married, divorced/ 
separated, widowed and never married. 
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Yearly Household Income (survey reported) 
For the purpose of analysis, the yearly household income of the participants was recorded as less 
than $25,000, $25,001 - $50,000, $50,001 - $75,000, $75,001 -$100,000 and greater than 
$100,000. 
Insurance Type  
We were interested to know if insurance status had any effect on the patient’s self-management 
behaviors and HbA1c control. The variable ‘Insurance Type’ was used to identify the type of 
Insurance coverage that the participants received and was categorized into the following: 
Medicare, Medicaid, private, self-paid, uninsured and other. 
Employment Status (survey reported) 
The employment status of the participants was recorded through the patient survey as full time, 
part-time, retired and not employed.  
Years since Diagnosis of Diabetes  
This variable measures the number of years for which the participants have been diagnosed with 
T2DM. This information was validated using the diagnosis date obtained from the EMR 
database. 
Recent HbA1c Level  
This variable measures the most recent self-reported HbA1c reading of the participants. This 
value was matched to the entry in their EMR records. 
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Smoking Status (survey reported) 
The smoking status of the participants was categorized into 3 groups: non-smoker (a person who 
has no history of smoking), former smoker (a person with a history of smoking, but is currently a 
non-smoker) and current smoker (a person who currently smokes). 
Co-morbidities  
This variable assesses the number of comorbidities the participants have a diagnosis for such as 
cardiovascular diseases (angina, heart attack, cardiovascular surgeries), hypertension, poor renal 
(kidney) function, peripheral neuropathy, autonomic neuropathy, retinopathy, amputation, 
depression, anxiety, obesity and gangrene (dead tissue). 
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Physicians 
Identification of Physician Sample 
 The physicians of the PPCP group were administered with a survey to gather information 
on their perceptions of patient barriers and their own challenges in addressing these barriers. The 
PPCP group consists of 39 physicians, who were all eligible for inclusion in the survey sample.  
Physician Survey Administration 
The physician survey was administered at a monthly meeting of the PPCP group. A total 
of 24 responses were collected of which three responses were from medical staff members. Since 
the perceptions of physicians who were directly involved in managing patients with T2DM were 
being assessed, the staff responses were not included in the analysis giving a final sample of 21 
physicians. 
Physician Survey 
The physician survey utilized both open- and closed-ended questions. Specifically, the 
questions probed how important and difficult the physicians perceived self-care activities was for 
their patients including regular moderate exercise, following a recommended diet, regular blood 
glucose testing, proper insulin administration and adherence to oral medications. The survey also 
asked the physicians about the proportion of their patients they believed were adherent to these 
self-care activities. Additionally, the study evaluated how important the physicians believed 
aspects of their practice such as physician-patient communication, patient health literacy and 
patient follow-up and how the physicians rated their performance on these measures and how 
satisfied they were with their performance. There was an interest in knowing the challenges 
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physicians encountered in managing their patients whose HbA1c levels are uncontrolled (HbA1c 
> 7); this data was collected using an open-ended question. Recurrent themes were identified 
using techniques suggested by Ryan and Bernard (repetitions, cutting and sorting, similarities 
and differences). Demographic information related to the physicians and their practice was 
collected in the survey.  
Description of Physician Survey Instruments 
 The objective of the physician survey was to identify the  
1. Demographic characteristics of the physician practices such as its location (urban/ rural), 
availability of staff support, and so on 
2. Information about the physician’s age, years in practice, number of T2DM patients 
examined per week and so on 
3. The physicians’ perceptions about their patients’ self-management behaviors and their 
practice’s performance in improving self-management in their patients 
4. The barriers that contribute to clinical inertia (physician’s inability to intensify treatment 
to help patients reach their unmet goals of care) in these physicians 
The questionnaire was examined for its face validity and content validity through expert 
opinions (opinions of investigators, PPCP physicians and PPCP pharmacist) about whether the 
items in the questionnaire measure the above objectives adequately and completely. The items 
which seemed not useful were removed from the questionnaire and those that received consensus 
among the experts were included in the final questionnaire. 
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Physician Related Variables 
Demographic Information 
Age 
This variable measures the age of the participating physicians in years. 
Gender 
The gender variable was used as an indicator of sex of the Physicians 
Years in Practice 
This variable records the number of years the physicians have spent in diabetes practice. 
Patients /Week 
This variable records the average number of patients with T2DM, the physicians examine per 
week. 
Reasons for Referral 
This variable enquires about the physicians’ reasons for referring the patients uncontrolled on 
T2DM to endocrinologists. 
Location 
The location variable identifies the physician practice as rural or urban. 
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Staff Support 
This variable seeks information about the type of staff support available in the physician 
practice: Nurse, Pharmacist, Others or None. 
Variables Assessing Physician Perceptions 
An important goal of the physician survey was to understand physician’s perceptions 
about the importance and level of difficulty of various self-care activities in their T2DM patients. 
The study also aimed to assess the proportion of patients the physicians believed were adherent 
to different self-care activities. The study also sought to understand the physicians’ perceptions 
about the importance of practice-related measures such as physician-patient communication, 
patient health literacy and patient follow-up. There was an interest in measuring how the 
physicians rated their performance on these measures and how satisfied they were with their 
performance. The physician survey also measured the challenges these physicians encounter in 
managing their T2DM patients through an open-ended question. The following variables were 
used to collect this information: 
Importance (Self-Care Activities) 
This variable assesses physician perceived importance of performing diabetes self-care activities 
such as regular moderate exercise, following a recommended diet, regular blood glucose testing, 
proper insulin administration and adherence to oral medication, using a 5-point Likert scale.  
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Difficulty (Self-Care Activities) 
This variable assesses physician perceived difficulty in performing diabetes self-care activities 
such as regular moderate exercise, following a recommended diet, regular blood glucose testing, 
proper insulin administration and adherence to oral medication, using a 5-point Likert scale.  
Adherence (Self-Care Activities) 
This variable assesses physicians’ perceptions about the proportion of their patients adhering to 
diabetes self-care activities such as regular moderate exercise, following a recommended diet, 
regular blood glucose testing, proper insulin administration and adherence to oral medication, 
using a 5-point Likert scale. 
Importance (Physician Practice Factors) 
This variable assesses physician perceived importance of practice related factors such as patient-
physician communication, patient health literacy and patient follow-up, using a 5-point Likert 
scale. 
Performance (Physician Practice Factors) 
This variable assesses the physicians’ perceptions of their performance on practice related factors 
such as patient-physician communication, patient health literacy and patient follow-up, using a 5-
point Likert scale. 
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Satisfaction (Physician Practice Factors) 
This variable assesses the physicians’ satisfaction with practice related factors such as patient – 
physician communication, patient health literacy and patient follow-up, using a 5-point Likert 
scale. 
Face-to-Face Interaction 
This variable collects information about the average number of face-to-face interactions the 
physicians have with their T2DM patients in a 3-month interval. 
Follow-Up 
This variable collects information on the number of times the physicians follow up with their 
patients between any two face-to-face visits. 
Reasons for No Follow up 
This variable enquires about the various reasons that are responsible for patients not seeking 
follow-up care. 
Responsibility of failure 
This variable records the extent to which the physicians feel responsible for their patients’ failure 
to achieve their self-management goals using a 4-point Likert scale. 
Challenges 
This variable gathers information about the challenges faced by Physicians in managing their 
patients with T2DM, using an open-ended question: “Please list the 5 most important barriers 
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responsible for clinical inertia n your practice.” Clinical inertia is defined as the lack of treatment 
intensification in patients who are not on evidence based goals for care. 
Institutional Review Board (IRB) Approval 
 The proposed study was conducted in accordance with the Institutional Review Board 
policies and procedures of Duquesne University. The study attempted to link the data collected 
from surveys to the patients’ clinical data, as obtained from their electronic medical records. 
Additionally, this study also probed the primary care physicians of these patients regarding their 
beliefs about their practice. Given the nature of the proposed study, an expedited review was 
approved by Duquesne University Institutional Review Board. 
Informed Consent 
 The patients in the sample were mailed an informed consent form at the time of study 
enrollment, informing them of the use of their medical information for research purposes and 
requesting their voluntary participation. To ensure confidentiality, patients who responded were 
tracked by the Principal Investigator (PI) using a code that was linked to the patient’s unique 
patient ID.  The survey data from the patients did not contain any identifying information except 
for the code corresponding to their unique patient IDs which were used to link the survey data 
with the EMR data extract.  The primary care physicians in the practice also had to provide an 
informed consent prior to participating in the study. 
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Statistical Analysis Plan 
 The statistical analyses for this study were performed using IBM SPSS Statistics 23 
software package. Two separate datasets were created from the patient survey and physician 
survey respectively. The analysis plan for the study objectives is described below: 
Patient Survey 
One aim of this study was to identify the barriers and facilitators to diabetes self-
management (DSM). Additionally, the objective was to explore which of these factors 
significantly predict DSM in the study population. Descriptive statistics were conducted for 
patient characteristics. Correlation between the variables that were both collected through patient 
survey and EMR database was reported using Cronbach’s α. Means and standard deviations were 
reported for continuous variables such as age. Frequencies and percentages were reported for 
categorical variables such as gender, marital status, level of education, race, insurance status, and 
so on. Some continuous variables such as age, HbA1c level and BMI (captured from EMR 
database) were converted to categorical variables to conduct appropriate analyses. Univariate 
regression models were run to study the impact of various study variables on DSMQ score and 
HbA1c level. Based on the results of the univariate regression analyses, significant predictors 
were entered in multinomial regression models, to identify a set of predictors that best predict 
HbA1c levels and DSMQ scores in these patients. Another aim of this study was to identify the 
differences in patients’ characteristics based on their readiness to change their health behavior. 
Univariate analyses were conducted to identify a set of predictors that best predict the patients’ 
readiness to change their health care behaviors. 
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Physician Survey 
Apart from assessing the patients’ perspectives about their diabetes self-care behaviors, 
an aim of this study was to assess their physicians’ perceptions about their practice and about 
what prevented their patients from achieving optimal self-management. Descriptive statistics 
were conducted to report the characteristics of the responding physicians and their practices. 
Means and standard deviations were reported for continuous variables such as age and years in 
practice. Frequencies and percentages were reported for categorical variables such as physicians 
feeling responsible for patient’s failure to reach self-management goals. Physicians’ perceptions 
about their patients’ self-management behaviors and their beliefs about their practices were also 
summarized. A qualitative component of the physician survey probed the physicians regarding 
the challenges they face in improving their diabetes patients’ self-management. Recurrent themes 
were identified using techniques suggested by Ryan and Bernard (repetitions, cutting and sorting, 
similarities and differences) and the most common themes were reported.71  
 
 
 
 
 
 
 
 59 
CHAPTER 4: RESULTS 
The primary aims of this study were to identify patient perceived barriers and facilitators 
to diabetes self-management, to assess patients’ readiness to change their diabetes self-
management behavior, to identify physician perceived barriers to diabetes self-management and 
to explore physicians’ challenges to overcome the barriers to self-management. This chapter 
provides an overview of the study findings. 
Patient Survey 
Survey Administration and Response Rate  
In order to collect the information about patient perceived barriers and facilitators to 
diabetes self-management, a one-time mail survey was administered to a random stratified 
sample of 2,100 patients. The survey was mailed on June 06, 2014 and the survey responses 
were collected over the next three months. A total of 210 responses (10% response rate) were 
received of which 161 responses (76.7%) were received within the first two weeks of survey 
administration (early responders) while 49 responses (23.3%) were received after two weeks of 
survey administration (late responders). The 10% response rate is lower than the average 
response rate for patients with T2DM as found in the literature (around 40%). The low response 
rate could be attributed to the absence of multiple mailings as per Dillman method and 
appropriate incentives. 23 Despite the low response rate, a sample size (n = 210) was sufficient to 
conduct all the proposed analyses. 
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Nonresponse bias analysis: 
We examined if early responders of the patient survey differed from late responders with 
respect to their characteristics. Late responders typically have characteristics similar to non-
responders and it is important to assess if there is any non-response bias due to low response rate. 
82, 83 It was found that early responders did not differ significantly from late responders with 
respect to the any patient characteristic or self-care behavior, with the p-value set at 0.05 thereby, 
increasing the confidence in the responses received (refer Table 4.1). 
Objective 1: To identify patient perceived barriers and facilitators to diabetes self-management 
Demographic characteristics 
Table 4.2 presents the demographic and clinical characteristics of the respondents. The 
respondents were predominantly Caucasians (93.80%), married (60%) and the sample consisted 
of 108 males (51.4%). The respondents’ age ranged from 24 years to 88 years (mean age= 63.68 
+ 11.79 years). A majority of respondents (55.70%) were in the 55-75 years’ age group. 17 
respondents did not report their age. Age of the respondents was also collected from their 
electronic medical records (EMR) which was consistent with the age reported by the patients in 
the survey.  Interestingly, age was missing for 6 respondents in their EMR as well. A sizable 
proportion of the respondents (53.4%) had at least some college education.   
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Table 4.1: Baseline Characteristics of Patient Sample (Stratified by Response Status) 
Characteristics Total Sample  
 
(N= 210) 
N (%)               
Early 
Responders  
(N=162) 
N (%) 
Late  
Responders  
(48) 
N (%)  
P Value 
Mean age (SD) 63.7 (11.7) 63.1 (11.5) 65.6 (12.3)  
Age Group 
46 – 55 Years 
56 – 65 Years 
> 65 Years 
 
41 (21.2) 
64 (33.2) 
88 (45.6) 
 
36 (24.3) 
50 (33.8) 
62 (41.9) 
 
5 (11.1) 
14 (31.1) 
26 (57.8) 
< 0.09 
Gender 
Male 
 
108 (51.4) 
 
87 (53.7) 
 
21 (43.7) 
0.23 
Female 102 (48.6) 75 (46.3) 27 (56.3)  
Ethnicity 
Caucasian 
African-American 
Asian 
Other 
 
197 (95.2) 
5 (2.4) 
2 (1.0) 
3 (1.4) 
 
154 (96.3) 
5 (3.1) 
0 (0.0) 
1 (0.6) 
 
43 (91.5) 
0 (0.0) 
2 (4.3) 
2 (4.3) 
< 0.01* 
Education 
High school/ vocational 
College or Some College 
Graduate 
 
97 (46.4) 
74 (35.4) 
38 (18.2) 
 
73 (45.3) 
55 (34.2) 
33 (20.5) 
 
24 (50.0) 
19 (39.6) 
5 (10.4) 
0.28 
Marital Status 
Currently Married 
Divorced/ Separated 
Widowed 
Never Married 
 
126 (60.3) 
32 (15.3) 
31 (14.8) 
20 (9.6) 
 
99 (61.5) 
24 (14.9) 
23 (14.3) 
15 (9.3) 
 
27 (56.3) 
8 (16.7) 
8 (16.7) 
5 (10.4) 
0.93 
Yearly Income 
≤ $25,000 
$25,001 - $50,000 
$50,001 - $75,000 
$75,001 - $100,000 
> $100,000 
 
58 (30.7) 
54 (28.6) 
33 (17.5) 
21 (11.1) 
23 (12.2) 
 
47 (31.8) 
43 (29.1) 
24 (16.2) 
16 (10.8) 
18 (12.2) 
 
11 (26.8) 
11 (26.8) 
9 (22.0) 
5 (12.2) 
5 (12.2) 
0.92 
Insurance 
Medicare 
Medicaid 
Private 
Self-Paid 
Other 
 
107 (52.5) 
9 (4.4) 
66 (32.4) 
6 (2.9) 
15 (7.4) 
 
79 (50.6) 
8 (5.1) 
49 (31.4) 
6 (3.8) 
1 (0.6) 
 
28 (58.3) 
1 (2.1) 
17 (35.4) 
0 (0.0) 
0 (0.0) 
< 0.5 
Employment 
Full – Time 
Part – Time 
Retired 
Unemployed 
 
53 (25.7) 
15 (7.3) 
114 (55.3) 
24 (11.7) 
 
40 (25.3) 
13 (8.2) 
85 (53.8) 
20 (12.7) 
 
13 (27.1) 
2 (4.2) 
29 (60.4) 
4 (8.3) 
0.62 
Smoking 
Current Smoker 
 
18 (8.7) 
 
15 (9.5) 
 
3 (6.3) 
0.41 
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Former Smoker 
Non-Smoker 
72 (35.0) 
116 (56.3) 
58 (36.7) 
85 (53.8) 
14 (19.4) 
31 (64.6) 
Referral to an 
Endocrinologist 
Yes 
No 
 
 
56 (27.7) 
146 (72.3) 
 
 
43 (27.6) 
113 (72.4) 
 
 
13 (28.3) 
33 (71.7) 
 0.93 
Comorbidities 
Cardiovascular Disease 
Hypertension 
Renal Failure 
Peripheral Neuropathy 
Retinopathy 
Depression 
Anxiety 
Obesity 
 
57 (27.1) 
156 (74.3) 
14 (6.7) 
39 (18.6) 
26 (12.4) 
50 (23.8) 
43 (20.5) 
62 (29.5) 
 
44 (27.2) 
120 (74.1) 
8 (4.9) 
30 (18.5) 
20 (12.3) 
36 (22.2) 
32 (19.8) 
49 (30.2) 
 
13 (27.1) 
36 (75.0) 
6 (12.5) 
9 (18.8) 
6 (12.5) 
14 (29.2) 
11 (22.9) 
13 (27.1) 
 
0.17 
0.90 
0.19 
0.97 
0.51 
0.48 
0.63 
0.67 
Chi square test were used with significance level set at p < 0.05.  
* Significant associations 
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The yearly household income of 53.5% respondents was under $50,000; 32.3% of the 
respondents were employed, 54.3% were retired, and 11.4% were unemployed. The respondents 
greatly varied in the number of years since their first diagnosis of diabetes. The duration ranged 
from 1 to 60 years with a mean duration of 13.03 ± 9.749 years. Over half of the respondents 
(55.2%) were non-smokers. A total of 107 patients (51%) were insured with Medicare while 71 
patients (33.8%) patients reported more than one source of insurance. 
The patient survey also assessed patients’ clinical attributes such as the comorbidities, 
latest HbA1c level and if the patients received any referrals to an endocrinologist by their 
primary care physician. Majority of respondents had comorbid hypertension (74.3%) and some 
other major comorbid conditions included obesity (29.5%), cardiovascular (27.1%), depression 
(23.8%) and anxiety (20.5%).  27.7% of the respondents were referred to an endocrinologist by 
their primary care physician.  
The HbA1c levels of the respondents ranged from 4.5 to 14.0 with a mean of 7.83 ± 1.69. 
A total of 59 survey respondents (28.10%) did not report their HbA1c level. The challenges of 
missing data or self-reports were overcome as HbA1c data was also collected from the EMR. 
The EMR HbA1c levels of the respondents ranged from 5.0 to 14.6 with a mean of 7.87 ± 1.69.  
EMR HbA1c was missing for only seven patients (3.30%). Wherever possible, missing survey 
data was supplemented with EMR data extracted from the patient records and was used for 
further analysis. Based on the HBA1c levels, three groups were created - ‘Well controlled’ 
(HbA1c ≤ 7), ‘Moderately Uncontrolled’ (7 < HbA1c ≥ 9), and ‘Severely Uncontrolled’ (HbA1c 
> 9). 
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Table 4.2: Baseline Characteristics of Patient Sample (Stratified by Glycemic Control) 
Characteristics Total Sample 
(N= 210) 
N (%)               
HbA1c ≤ 7 
(N=67) 
N (%) 
7 < HbA1c ≤ 9 
(N=82) 
N (%)  
HbA1c > 9 
(N=37) 
N (%) 
P Value 
Mean age (SD) 63.5 (11.8) 66.3 (10.2) 62.7 (12.7) 60.6 (11.9)  
Age Group 
46 – 55 Years 
56 – 65 Years 
> 65 Years 
 
41 (19.5) 
64 (30.50) 
88 (25.20) 
 
5 (12.2) 
21 (35.6) 
41 (47.7) 
 
25 (61.0) 
23 (39.0) 
34 (39.5) 
 
11 (26.8) 
15 (25.4) 
11 (12.8) 
< 0.01* 
Gender 
Male 
 
108 (51.40) 
 
33 (44.0) 
 
50 (56.8) 
 
22 (55.0) 
0.24 
Female 102 (48.60) 42 (56.0) 38 (43.2) 18 (45.0)  
Ethnicity 
Caucasian 
African-American 
Asian 
Other 
 
197 (93.80) 
5 (2.4) 
2 (1.0) 
3 (1.4) 
 
70 (94.6) 
4 (5.4) 
0 (0.0) 
0 (0.0) 
 
83 (95.4) 
0 (0.0) 
2 (2.3) 
2 (2.3) 
 
38 (95.0) 
5 (2.5) 
2 (1.0) 
3 (1.5) 
0.17 
Education 
High school/ 
vocational 
Some College 
College 
Graduate 
 
97 (46.20) 
35 (16.70) 
39 (18.60) 
38 (18.10) 
 
34 (36.5) 
13 (37.1) 
16 (44.4) 
12 (31.6) 
 
38 (40.9) 
14 (40.0) 
14 (38.9) 
22 (57.9) 
 
21 (22.6) 
8 (22.9) 
6 (16.7) 
4 (10.5) 
0.40 
Marital Status 
Currently Married 
Divorced/ Separated 
Widowed 
Never Married 
 
126 (60.00) 
32 (15.20) 
31 (14.80) 
20 (9.50) 
 
46 (37.4) 
11 (35.5) 
11 (37.9) 
7 (36.8) 
 
52 (42.3) 
16 (51.6) 
13 (44.8) 
7 (36.8) 
 
25 (20.3) 
4 (12.9) 
5 (17.2) 
5 (26.3) 
0.91 
Yearly Income 
≤ $25,000 
$25,001 - $50,000 
$50,001 - $75,000 
$75,001 - $100,000 
≥ 100,001 
 
58 (27.60) 
54 (25.70) 
33 (15.70) 
21 (10.00) 
23 (11.00) 
 
19 (33.9) 
17 (32.7) 
12 (38.7) 
8 (40.0) 
6 (26.1) 
 
22 (39.3) 
26 (50.0) 
13 (41.9) 
10 (50.0) 
11 (47.8) 
 
15 (26.8) 
9 (17.3) 
6 (19.4) 
2 (10.0) 
6 (26.1) 
0.81 
Insurance 
Medicare 
Medicaid 
Private 
Self-Paid 
Other 
 
107 (51.00) 
9 (4.30) 
66 (31.40) 
6 (2.90) 
15 (7.10) 
 
51 (49.0) 
3 (33.3) 
16 (24.6) 
3 (50) 
1 (7.7) 
 
38 (36.5) 
4 (44.4) 
34 (52.3) 
2 (33.3) 
8 (61.5) 
 
15 (14.4) 
2 (22.2) 
15 (23.1) 
1 (16.7) 
4 (30.8) 
< 0.05* 
Employment 
Full – Time 
Part – Time 
Retired 
Unemployed 
 
53 (25.20) 
15 (7.10) 
114 (54.30) 
24 (11.40) 
 
15 (28.3) 
6 (42.9) 
45 (41.3) 
8 (34.8) 
 
27 (50.9) 
4 (28.6) 
46 (42.2) 
9 (39.1) 
 
11 (20.8) 
4 (28.6) 
18 (16.5) 
6 (26.1) 
0.58 
Smoking     0.50 
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Current Smoker 
Former Smoker 
Non-Smoker 
18 (8.60) 
72 (34.30) 
116 (55.20) 
6 (33.3) 
27 (39.7) 
40 (35.4) 
6 (33.3) 
31 (45.6) 
50 (44.2) 
6 (33.3) 
10 (14.7) 
23 (20.4) 
Referral to an 
Endocrinologist 
56 (26.70) 14 (25.9) 24 (44.4) 16 (29.6) < 0.05* 
Comorbidities 
Cardiovascular Disease 
Hypertension 
Renal Failure 
Peripheral Neuropathy 
Retinopathy 
Depression 
Anxiety 
Obesity 
 
57 (27.10) 
156 (74.30) 
14 (6.70) 
39 (18.60) 
26 (12.40) 
50 (23.80) 
43 (20.50) 
62 (29.50) 
 
20 (37.0) 
59 (39.3) 
3 (23.1) 
11 (29.7) 
6 (26.1) 
15 (30.6) 
18 (42.9) 
22 (36.7) 
 
19 (35.2) 
65 (43.3) 
5 (38.5) 
17 (45.9) 
12 (52.2) 
22 (44.9) 
18 (42.9) 
28 (46.7) 
 
15 (27.8) 
26 (17.3) 
5 (38.5) 
9 (24.3) 
5 (21.7) 
12 (24.5) 
6 (14.3) 
10 (16.7) 
 
0.17 
0.29 
0.19 
0.55 
0.51 
0.48 
0.53 
0.73 
Chi square test were used with significance level set at p < 0.05.  
*Significant associations  
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Validation of survey responses using EMR 
 This study utilized survey methods to collect information about patient demographic 
characteristics, clinical outcomes such as most recent HbA1c level and patient beliefs about self-
care activities. Additionally, information regarding their demographic characteristics and most 
recent HbA1c level was also collected from their EMR. For variables collected through both 
sources, the correlation between the survey responses and recorded EMR responses were 
examined to validate the survey responses. It was found that age measured through EMR was 
strongly correlated with age captured through survey response (Pearson’s correlation r = 0.940, p 
< 0.0001). Similarly, the HbA1c recorded in the EMR significantly correlated with the self-
reported HbA1c level, though the correlation was moderate (Pearson’s correlation r = 0.629, p < 
0.001). 
Patients’ Self-Care Behaviors 
 In addition to the demographic variables, the patient survey collected information about 
the patient’s self-care behaviors such as diabetes self-management, knowledge of diabetes, 
attitudes and beliefs regarding their disease, their readiness to change their health related 
behaviors, and their preference for oral hypoglycemic agents and/ or insulin. These self-care 
behaviors were measured using standardized questionnaires: 
a. Diabetes Self-Management Questionnaire (DSMQ) 
The total DSMQ scores ranged from 2.08 to 9.17 with a mean score of 6.75 ± 1.31. 
Higher scores indicate more desirable self-management behavior. DSMQ scores were divided 
into 4 quartiles: 0.00-2.50, 2.51-5.00, 5.01-7.50 and 7.50-10.00. As only one respondent scored 
below 2.51, we merged the lower two categories into 0.00-5.00 for the purpose of further 
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analyses. The final categories were ‘Low self-management’ (DSMQ score of 5 or below), 
‘Average self-management’ (DSMQ score between 5.01 and 7.50), and ‘High self-management 
(DSMQ score above 7.50). A total of 17 respondents (8.4%) reported low self-management, 124 
respondents (61.1%) reported average self-management and 62 respondents (30.5%) reported 
high self-management. A higher proportion of patients with HbA1c < 7 had higher DSMQ scores 
as compared to uncontrolled HbA1c groups (refer Table 4.3).  
b. Diabetes subscale of Diabetes, Hypertension and Dyslipidemia (DHL) Questionnaire 
The possible scores on the DHL instrument range from 0-10. The DHL scores were 
categorized as ‘Low knowledge’ for scores ≤ 5 and ‘High knowledge’ for scores > 5. The 
respondents’ DHL scores ranged from 0 to 8 with a mean DHL score of 4.82 ± 1.31. A total of 
159 respondents (75.70%) were found to have low knowledge of their diabetes while 51 
respondents (24.30%) were found to have high knowledge of their diabetes (Table 4.4).  
c. The Revised Illness Perception Questionnaire (IPQ - R) 
The Revised Illness Perception Questionnaire (IPQ - R) was employed to understand the 
patients’ attitudes and beliefs about their disease. Some items are negatively worded to minimize 
respondent bias. In the IPQ-R questionnaire (refer Table 4.5), items 1 through 6 capture the 
respondents’ beliefs about the timeline (acute/ chronic) of their disease. A majority of 
respondents perceived that their illness is chronic in nature and will last a long time. A majority 
of the patients perceived their illness to have serious consequences (items 7 through 12). 
However, the financial consequences were perceived to be serious by only 42.8% of the 
respondents. A small proportion of respondents (29.60%) agreed that their illness caused 
difficulties for those who are close to the patients (caregivers). Items 13 through 17 measured the 
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respondents’ perceptions about their personal control. A majority of respondents believed that 
they had the power to control their illness. Items 18 through 20 measure the respondents’ 
perceptions about their treatment control. A majority of respondents perceived that their 
treatment can control their illness. Items 21 through 25 measures perceived coherence of disease. 
A majority of respondents did not find their disease puzzling, and had a clear picture or 
understanding of their illness. Items 26 through 28 measured the respondents’ perceptions about 
the cyclic nature of the symptoms of their illness. Relatively few respondents agreed that the 
symptoms of their illness changes from day to day or they come and go in cycles. A greater 
proportion of respondents perceived the symptoms of their disease to be consistent over time. 
Items 29 through 34 measured the emotional representations of respondents about their disease. 
A majority of respondents disagreed that their illness makes them depressed or upset, worries 
them, makes them angry, anxious or afraid. 
d. Readiness to Change 
The respondents were enquired about their readiness to change their healthcare behavior 
in accordance with the Trans-theoretical model of change. It was found that of the patients for 
whom HbA1c level was available through the EMR (N = 193), 21 patients (10.9%) were in the 
pre-contemplation or contemplation phase, 41 patients (21.2%) were in the preparation phase, 93 
patients (48.2%) were in the action phase and 38 patients (19.7%) were in the maintenance 
phase. A higher proportion of patients who had HbA1c levels < 7, were in Action and 
Maintenance phase, as compared to patients in other groups (Table 4.6). 
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e. Willingness to take Medications 
A total of 63 patients (30%) showed low willingness for taking insulin (score: 0-5) while 
122 patients (58.1%) showed high willingness to take insulin (score: 6-10) (Table 4.7). The mean 
willingness to take insulin score was 6.94 ± 3.58. Responses were missing for 25 patients 
(11.9%), who chose not to answer that question.  Only 18 patients (8.6%) had a low willingness 
for taking oral hypoglycemic agents (score: 0-5), with 174 patients (82.9%) in favor of taking 
them (score: 6-10). The mean willingness to take hypoglycemic agents score was 9.06 ± 2.24. 18 
respondents (8.6%) did not respond to this question. The willingness to take either medication 
was not correlated with the patients’ readiness to change. 
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Table 4.3: Diabetes Self-Management Questionnaire (DSMQ) 
Category Total Sample 
N (%) 
HbA1c ≤ 7 
 
7 < HbA1c ≤ 9 HbA1c > 9 P value 
0.00 to 2.50 
2.51 to 5.00 
5.01 to 7.50 
7.51 to 10.00 
1 (0.5) 
16 (7.9) 
124 (61.1) 
62 (30.5) 
0 (0) 
1 (1.3) 
47 (62.7) 
27 (36.0) 
0 (0) 
8 (9.1) 
56 (63.6) 
24 (27.3) 
1 (2.5) 
7 (17.5) 
21 (52.5) 
11 (27.5) 
< 0.05 
Chi square test was performed with significance level set at p < 0.05. 
Higher DSMQ score suggests better self-management of diabetes. 
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Table 4.4: Diabetes, Hypertension, and  Hyperlipidemia (DHL) Questionnaire  
Category Total Sample 
N (%) 
HbA1c ≤ 7 
 
7 < HbA1c ≤ 
9 
HbA1c > 9 P value 
Low (0-5) 
High (6-10) 
159 (75.7) 
51 (24.3) 
59 (78.7) 
16 (21.3) 
71 (80.7) 
17 (19.3) 
26 (65.0) 
14 (35.0) 
0.13 
Chi square test was performed with significance level set at p < 0.05.  
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Table 4.5: Revised Illness Perception Questionnaire (IPQ-R) 
Sr. 
no. 
Item Proportion of respondents (%) 
  Strongly Agree  Strongly 
Disagree 
A. Timeline of disease (acute/ chronic) 
1 My illness will last a short time 10.0 1.0 3.8 9.5 73.3 
2 My illness is likely to be permanent rather than 
temporary 
62.4 10.0 9.0 3.3 11.9 
3 My illness will last a long time 62.9 9.5 11.4 3.3 8.6 
4 This illness will pass quickly 9.0 0.0 3.8 7.1 76.2 
5 I expect to have this illness for the rest of my life 61.4 9.5 9.5 2.4 12.9 
6 My illness will improve in time 11.4 15.7 21.0 14.8 32.4 
B. Consequences 
7 My illness is a serious condition 63.8 15.7 5.7 2.9 9.5 
8 My illness has major consequences on my life 56.2 14.8 11.0 6.7 9.5 
9 My illness does not have much effect on my life 9.5 6.2 18.1 13.3 51.0 
10 My illness strongly affects the way other see me 8.6 4.8 21.4 13.3 49.0 
11 My illness has serious financial consequences 25.2 17.6 27.1 12.4 14.3 
12 My illness causes difficulties for those who are 
close to me 
14.8 14.8 21.9 12.4 31.4 
C. Personal Control 
13 There is a lot I can do to control my illness 61.4 22.4 8.6 1.4 3.8 
14 What I do can determine whether my illness gets 
better or worse 
59.0 19.0 11.4 1.4 5.2 
15 The course of my illness depends on me 54.8 22.9 9.0 5.7 5.2 
16 Nothing I do will affect my illness 8.1 3.8 5.7 10.0 68.6 
17 I have the power to influence my illness 54.3 21.9 12.4 3.8 5.2 
D. Treatment Control 
18 The negative effects of my illness can be 
prevented by my treatment 
34.8 28.6 22.9 4.8 5.7 
19 Treatment can control my illness 49.0 28.1 11.9 2.4 6.2 
20 There is nothing that can help my illness 6.2 2.4 8.6 11.4 68.1 
E. Perceived Coherence 
21 The symptoms of my illness are puzzling to me 7.6 11.9 21.0 18.6 38.1 
22 My illness has no meaning to me 7.1 2.9 8.6 8.6 69.5 
23 I don’t understand my illness 5.7 7.6 19.0 15.7 48.6 
24 My illness doesn’t make any sense to me 6.7 8.1 14.8 17.6 49.0 
25 I have a clear picture or understanding of my 
illness 
36.7 20.5 23.3 10.0 5.7 
F. Timeline (Cyclic Nature of Disease) 
26 The symptoms of my illness change from day to 
day 
16.2 13.3 25.7 16.2 25.2 
27 My symptoms come and go in cycles 13.8 10.5 20.5 19.5 32.4 
28 I go through cycles in which my illness gets 
better and worse 
17.1 12.4 26.7 16.7 23.3 
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G. Emotional Representation of Disease 
29 I get depressed when I think about my illness 16.2 13.8 18.1 13.3 36.2 
30 When I think about my illness I get upset 13.8 11.9 21.0 9.0 40.5 
31 My illness makes me feel angry 14.8 11.0 17.6 13.3 40.0 
32 My illness does not worry me 8.1 10.5 17.6 19.5 40.5 
33 My illness makes me feel anxious 11.4 11.0 26.7 10.5 27.1 
34 My illness makes me feel afraid 11.4 13.8 19.5 20.0 32.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 74 
Table 4.6: Readiness to Change 
Category Total Sample 
N = 193 (%) 
HbA1c ≤ 7 
 
7 < HbA1c ≤ 9 HbA1c > 9 P value 
Pre-
contemplation & 
contemplation 
21 (10.9) 6 (8.5) 10 (11.8) 5 (13.5) < 0.61 
Preparation 41 (21.2) 11 (15.5) 23 (27.1) 7 (18.9) 
Action 93 (48.2) 38 (53.5) 37 (43.5) 18 (48.6) 
Maintenance 38 (19.7) 16 (22.5) 15 (17.6) 7 (18.9) 
Chi square test was performed with significance level set at p < 0.05. 
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Table 4.7: Willingness to Take Medications    
Category Total Sample 
N (%) 
HbA1c ≤ 7 
 
7 < HbA1c ≤ 
9 
HbA1c > 9 P value 
OHAs  
0-5 
6-10 
 
18 (8.6) 
174 (82.9) 
 
8 (11.0) 
65 (89.0) 
 
7 (9.5) 
67 (90.5) 
 
2 (5.1) 
37 (94.9) 
0.59 
Insulin 
0-5 
6-10 
 
63 (30.0) 
122 (70.0) 
 
30 (47.6) 
33 (52.4) 
 
23 (28.4) 
58 (71.6) 
 
7 (19.4) 
29 (80.6) 
< 0.01 
Chi square tests were performed and significance level was set at p < 0.05. 
Willingness to take insulin was higher in severely uncontrolled patients compared to other groups. 
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Univariate Relationships 
Univariate relationships between HbA1c control and respondent characteristics and self-
care behaviors were examined to identify variables that were significantly associated with 
HbA1c control in this population. Other dependent variables in this study were readiness to 
change and level of self-management as measured by the DSMQ questionnaire. Univariate 
associations between these variables, and respondent characteristics and self-care behaviors were 
also examined. Chi square statistic was used to examine these associations. Fisher’s exact test 
was used by SPSS instead of a chi square test, if any cell size was less than or equal to 5. 
Relationships between HbA1c control and Patient Characteristics: 
Age was significantly associated with HbA1c control, indicating that the HbA1c control 
varied significantly across age groups (chi square = 15.73, p < 0.01) (Table 4.8). Other variables 
that were significantly associated with HbA1c control were referral to an endocrinologist (chi 
square = 6.17, p < 0.05), diabetes self-management measured through DSMQ (chi square = 
12.01, p < 0.05), willingness to take insulin (chi square = 9.8, p < 0.01), and insurance status (chi 
square = 12.03, p < 0.05). HbA1c control was not associated with years since diagnosis, 
willingness to take OHAs, readiness to change, gender, education level, marital status, annual 
income, employment status, smoking status, knowledge of diabetes measured by DHL 
questionnaire. 
Relationships between DSMQ Scores and Patient Characteristics: 
The Diabetes Self-Management Questionnaire (DSMQ) measured the level of self-
management in the study population. The DSMQ scores were significantly associated with the 
HbA1c control as measured from EMR (chi square = 12.01, p < 0.05) and with readiness to 
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change (chi square = 33.04, p < 0.001) (Table 4.9). The association between DSMQ score and 
variables such as age, willingness to take insulin or OHAs, response status, the patient’s 
knowledge of diabetes as measured by the DHL questionnaire, years since diagnosis of diabetes, 
referral to an endocrinologist, smoking status, employment status, insurance coverage, marital 
status, annual income, and level of education. 
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Table 4.8: Relationship between HbA1c and Patient Characteristics 
Characteristics χ2 D.F. p – value 
Age 17.19 4 < 0.01 
Diabetes Self-Management (DSMQ) 12.01 4 < 0.05 
Willingness to take Insulin 9.80 2 < 0.01 
Insurance Status 
Referral to an Endocrinologist 
12.03 
6.17 
4 
2 
< 0.05 
< 0.05 
Chi square tests were performed and significance level was set at p < 0.05. 
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Table 4.9: Relationships between Self-Management (DSMQ) and Patient Characteristics 
Characteristics χ2 D.F. p – value 
HbA1c Control 12.01 4 < 0.05 
Readiness to Change 33.04 6 < 0.001 
Chi square tests were performed and significance level was set at p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 80 
Determinants of Glycemic Control 
An objective of this study was to identify the factors associated with glycemic control in 
the study population. Glycemic control measured through most recent HbA1c value in EMR is 
the primary outcome variable in this study. It is operationalized as well-controlled (HbA1c ≤ 7), 
moderately uncontrolled (7 < HbA1c > 9), and severely uncontrolled (HbA1c ≥ 9). As the 
response variable (HbA1c control) has more than two categories, multinomial logistic regression 
was utilized. A backward stepwise approach was used to specify the model. The first model 
tested for main effects and all the independent (predictor) variables were entered in the model. 
The backward stepwise approach utilized 0.1 as the probability for a variable to exit the model. 
This procedure provided a model with age, DSMQ score, ‘willingness to take insulin’, and level 
of education. In the second model, the variables observed in the first model were forced entered 
and the interactions of age with other variables were entered in a stepwise manner. None of the 
interaction terms were significant and the resulting model was the same as model 1. The results 
of the multinomial regression model are presented in the Table 4.10 below: 
𝑙𝑜𝑔𝑖𝑡 [𝐸(𝑌)|𝑋𝑖]
=  𝛽0 + 𝛽1𝑠𝑒𝑙𝑓 − 𝑚𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡 (𝐷𝑆𝑀𝑄) +  𝛽2𝑎𝑔𝑒 𝑙𝑒𝑠𝑠 𝑡ℎ𝑎𝑛 50 +  𝛽3𝑎𝑔𝑒 50
− 65 +  𝛽4𝑙𝑜𝑤 𝑤𝑖𝑙𝑙𝑖𝑛𝑔𝑛𝑒𝑠𝑠 𝑡𝑜 𝑡𝑎𝑘𝑒 𝑖𝑛𝑠𝑢𝑙𝑖𝑛
+  𝛽5𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛 ℎ𝑖𝑔ℎ 𝑠𝑐ℎ𝑜𝑜𝑙 𝑜𝑟 𝑙𝑒𝑠𝑠
+  𝛽6𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑙𝑙𝑒𝑔𝑒 𝑜𝑟 𝑠𝑜𝑚𝑒 𝑐𝑜𝑙𝑙𝑒𝑔𝑒 
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Table 4.10: Parameter Estimates from Multinomial Logistic Regression for HbA1c control 
 95% CI for Odds Ratio 
Lower Odds Upper 
Moderately Uncontrolled Vs. Well-controlled 
DSMQ score 0.47 0.67 0.95 
Age < 50 years 1.45 4.90 16.49 
Age 50 – 65  0.62 1.65 4.42 
Age > 65 Ref.   
Low willingness to take Insulin 0.11 0.30 0.80 
High willingness to take Insulin Ref.   
Education high school or less 0.15 052 1.77 
Education college or some college 0.07 0.25 0.86 
Education graduate Ref.   
Severely Controlled Vs. Well-controlled 
DSMQ score 0.38 0.57 0.76 
Age < 50 years 1.42 6.37 28.51 
Age 50 – 65  0.95 3.20 10.85 
Age > 65 Ref.   
Low willingness to take Insulin 0.03 0.14 0.56 
High willingness to take Insulin Ref.   
Education high school or less 0.41 2.68 17.61 
Education college or some college 0.16 1.03 6.85 
Education graduate Ref.   
Note: R2 = 0.27 (Cox and Snell) and 0.31 (Nagelkerke); Model χ2 (16) = 41.23, p < 0.01 
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Patient’s level of self-management as measured by DSMQ scores was significantly 
associated with HbA1c control. A unit increase in DSMQ score was associated with 49% 
decreased odds of being moderately uncontrolled, and 75% decreased odds of being severely 
uncontrolled than well-controlled. Age was significantly associated with HbA1c control. 
Specifically, patients aged younger than 50 years were 4.9 times more likely to be moderately 
uncontrolled (OR=4.9, 95%CI=1.45, 16.49), and 6.4 times more likely to be severely 
uncontrolled (OR=6.37, 95%CI=1.42, 28.51) than well-controlled as compared to patients over 
65 years of age. Patients who showed low willingness to take insulin were 7.15 times less likely 
to be moderately uncontrolled than well-controlled as compared to patients who showed high 
willingness to take insulin (OR=0.30, 95%CI=0.11-0.80), and 3.3 times less likely to be severely 
uncontrolled than well-controlled (OR=0.14, 95%CI=0.03-0.56). Interestingly, patients with 
college education were 4 times less likely to be moderately uncontrolled than well-controlled as 
compared to patients with graduate level education (OR=0.25, 95%CI=0.07-0.86). The 
associations of other variables in the regression model with HbA1c control remained non-
significant. 
Objective 2: To assess patients’ readiness to change their diabetes self-management behavior 
Relationships between Readiness-to-Change and Patient Characteristics 
The variable ‘readiness to change’ measured the patients’ willingness to change their 
diabetes related behaviors. Patients who were referred to an endocrinologist by their primary care 
physicians differed significantly in their readiness to change their diabetes related behaviors (chi 
square = 11.86, p < 0.01) (Table 4.11). Additionally, self-management level as measured by 
DSMQ was significantly associated with readiness to change (chi square = 33.04, p < 0.001). 
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Demographic variables such as age, gender, ethnicity, education, marital status, annual income, 
insurance status, employment status, and knowledge as measured by DHL, were not significantly 
associated with readiness to change.  
Physician Survey 
Objective 3: To identify physician perceived barriers to diabetes self-management. 
The physician survey collected information about the physicians’ beliefs about their 
clinical practice and their patients’ self-management behaviors. The target sample was composed 
of physicians working in the PPCP group (n = 39). The survey was administered during the 
PPCP group’s monthly meeting held in June 2014. Out of a total sample of 39, 24 responses 
were obtained which included 21 physicians and 3 medical staff members (1 physician assistant, 
1 transition-of-care liaison and 1 nurse practitioner). The physicians were all males and the 
medical staff members were all females. The analyses only included responses from the 21 
physicians (response rate = 53.8%) as we were interested in assessing the barriers to diabetes 
self-management as perceived by providers, who were directly involved in treating this patient 
population. 
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Table 4.11: Relationships between Readiness to Change and Patient Characteristics 
Characteristics χ2 D.F. p – value 
Level of Self-management (DSMQ) 33.04 6 < 0.001 
Referral to an Endocrinologist 11.11 3 < 0.01 
Chi square tests were performed and significance level was set at p < 0.05. 
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Demographic and Practice Characteristics: 
The survey respondents included 21 physicians and 3 medical staff members. The 
analyses were conducted on responses from the 21 physicians only. 71.42% respondents were 
older than 50 years of age (mean = 53.81 ± 8.93). Over 50% of the respondents (13 out of 24) 
had more than 25 years of clinical experience (mean = 23.90, SD ± 9.19). 50% of the 
respondents had their practice in an urban setting. The respondents examined from 5 to 60 
patients with T2DM per week (mean = 20.95 ± 12.06) and a majority of physicians (76.20%) 
spent less than 20 minutes on a face-to-face visit (refer Table 4.12).  
The physician questionnaire also enquired about other attributes of the physicians’ 
practices such as the number of face-to-face interactions they have with their patients with 
T2DM in a 3-month period and the number of follow-ups they conduct between two face-to-face 
interactions. A majority of physicians had 1 – 2 face-to-face interactions with their patients with 
T2DM every 3 months. Interestingly, around 20% of physicians interacted face-to-face with their 
T2DM patients more than 5 times in a 3-month interval. Follow-up was conducted by over 80% 
of the respondents, with 14.28% respondents following up with their patients at least 3 times 
between two face-to-face visits. Follow-up care was offered by all of the participating 
physicians’ practices. Therefore, the physician survey also enquired about the reasons for not 
receiving follow-up care in those patients who did not receive/ seek follow-up. Over half of the 
respondents (57.10%) agreed that follow up care was not sought by some patients as they 
believed they have adequate knowledge of the disease and thus, do not require follow-up. The 
respondents did not believe that their lack of contact with patients was a reason for no follow up.  
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Table 4.12: Characteristics of Physician Practice 
Continuous Variables 
Characteristics Mean (SD) 
Age 53 ± 8.93 
Years in Practice 23.9 ± 9.19 
Number of Patients Examined Per Week 20.95 ± 12.06 
Categorical Variables 
Characteristics Total Sample (21) 
N (%) 
Age Category 
≤ 50 years 
> 50 years 
 
6 (28.58) 
15 (71.42) 
Years of Experience 
≤ 25 years 
> 25 years 
 
8 (38.1)  
13 (61.9) 
Location of Practice 
Urban 
Rural 
 
11 (52.4) 
10 (47.6) 
Average time per patient per visit 
15 min 
20 min 
25 min 
30 min 
 
9 (42.9) 
7 (33.3) 
2(9.5) 
3 (14.3) 
Number of patients per week 
≤ 10 
11 – 20 
> 20 
 
3 (14.3) 
10 (47.6) 
7 (33.3) 
Number of interactions in a 3-month interval 
1 
2 
 
14 (66.7) 
7 (33.3) 
Number of follow up visits in a 3-month 
interval 
2 
3 
 
 
18 (85.7) 
3 (14.3) 
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Around 19% of the respondents believed lack of time to interact with patients to be a reason for 
no follow up in their patients. 23.8% of the respondents believed that patients cannot afford 
follow-up care. Lack of internal support (staff, funding, materials and equipment) was not 
considered as a reason for ‘no follow-up’ by over 80% of the respondents. Other reasons 
provided by physicians include non-compliance, patient indifference and patients’ lack of 
concern for their own health and their inability to keep up with appointments.  
The respondents were requested to report the reasons for referring their patients with 
T2DM to an endocrinologist. 19 respondents considered the uncontrolled nature of their patients’ 
disease as a reason for the referral. Six respondents cited the need for insulin therapy or insulin 
pump as a reason for referral to an endocrinologist. Non-compliance and poor adherence were 
the other reasons commonly cited by the respondents as reasons for referral to the 
endocrinologist. Presence of co-morbidities (other endocrine disorders such as T1DM), extreme 
resistance to insulin, necessity of multiple adjustments to therapy, and patient request were other 
reasons noted by the respondents for the referral.  
Beliefs about Patient Self-Care: 
An important objective of the physician questionnaire was to identify the physicians’ 
perceptions about the importance and level of difficulty of their patients’ self-care activities. 
These activities include regular moderate exercise, following a recommended diet, regular blood 
glucose testing, proper insulin administration and adherence to oral medication. In doing so, a 5-
point Likert scale was utilized where 1 = ‘not important at all/ not difficult at all’ and 5 = 
‘extremely important/ extremely difficult’. Additionally, physicians were asked the proportion of 
their patients who were adherent to these self-care activities. Again, a 5-point Likert scale (1 = 
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‘less than 30%’, 2 = ‘30-50%’, 3 = ‘50-70%’, 4 = ’70-90%’ and 5 = ‘more than 90 %’) was 
utilized to measure the proportion of adherent patients (as perceived by their physicians). 
Table 4.13 summarizes the survey responses about the physicians’ beliefs about their 
patients’ self-care activities. Self-care activities included Regular moderate exercise, following a 
recommended diet, regular blood glucose testing, proper insulin administration (in patients who 
need insulin therapy), and adherence to oral medications. It was observed that a majority of 
physicians (around 95%) considered these self-care activities extremely important. A higher 
degree of variation was observed in the physicians’ perception of the level of difficulty the 
patients face in performing these activities. However, over half the respondents considered 
regular moderate exercise (85.71%), following a recommended diet (80.95%) and proper insulin 
administration (61.90%) as at least ‘difficult’. Interestingly over half the respondents perceived 
adherence to medication and regular blood glucose testing as ‘slightly difficult’ or ‘not difficult 
at all’ (52%, 38%). 76.19% of the respondents believed that less than 50% of their patients are 
adherent to regular moderate exercise or following a recommended diet. However, at least 60% 
of the respondents believed that over half of their patients were adherent to regular blood glucose 
testing, proper insulin administration and took their oral medications as prescribed.  
Beliefs about Physician Practice: 
The study sought to identify the physicians’ beliefs about aspects of their practices such 
as the physician-patient communication, patient health literacy and patient follow-up. 
Specifically, the study assessed how important the physicians believed these aspects of their 
practice to be in managing their patients with T2DM, how they rated their performance on these 
aspects, and how satisfied they were with their performance. A 5-point Likert scale was utilized 
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to collect this information. It was found that all the aforementioned aspects were considered 
extremely important or very important by a majority of respondents (95.23% - 100.00%). 
Overall, physicians rated their performance on these measures positively. A majority of 
respondents (over 90%) showed satisfaction with their performance on these measures (Table 
4.14). 
A sizable proportion of the respondents (66.67 %) considered themselves responsible to 
some extent for their patients’ failure to achieve their self-management goals. However, around 
30% of the respondents believed they are not responsible for their patients’ failure to achieve 
their self-management goals. Interestingly, there was a strong association between physician 
perceived responsibility of patient’s failure to achieve self-management goals and self-rated 
performance on patient follow-up (chi square = 27.34, p < 0.001), self-rated satisfaction with 
patient follow up (chi square = 21.83, p < 0.01), and self-rated satisfaction with patient health 
literacy (chi square = 17.68, p < 0.01). 
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Table  4.13: Self-care activities 
 Regular moderate 
exercise 
Following a 
recommended diet 
Regular blood 
glucose testing 
Proper insulin 
administration 
Adherence to oral 
medication 
 N (%) N (%) N (%) N (%) N (%) 
 Importance 
Not important at all 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Slightly Important 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Important 0 (0) 0 (0) 7 (33.3) 0 (0) 0 (0) 
Very important 1 (4.8) 2 (9.5) 4 (19.0) 1 (4.8) 1 (4.8) 
Extremely Important 20 (95.2) 23 (90.5) 10 (47.6) 20 (95.2) 20 (95.2) 
Total 21 (100) 21 (100) 21 (100) 21 (100) 21 (100) 
 Difficulty 
Not difficult at all 0 (0) 2 (9.5) 6 (28.6) 2 (9.5) 5 (23.8) 
Slightly difficult 3 (14.3) 2 (9.5) 5 (23.8) 6 (28.6) 11 (52.4) 
Difficult 9 (42.9) 6 (28.6 ) 6 (28.6) 10 (47.6) 4 (19) 
Very difficult 3 (14.3) 5 (23.8) 4 (19.0) 2 (9.5) 1 (4.8) 
Extremely difficult 6 (28.6) 6 (28.6) 0 (0) 1 (4.8) 0 (0) 
Total 21 (100) 21 (100) 21 (100) 21 (100) 21 (100) 
 Proportion of adherent patients 
Less than 30% 9 (42.9) 7 (33.3) 3 (14.3) 1 (4.8) 1 (4.8) 
30-50% 7 (33.3) 9 (42.9) 4 (19.0) 1 (4.8) 1 (4.8) 
50-70% 4 (19.0) 3 (14.3) 9 (42.9) 9 (42.9) 9 (42.9) 
70-90% 1 (4.8) 2 (9.5) 5 (23.8) 9 (42.9) 7 (33.3) 
More than 90% 0 (0) 0 (0) 0 (0) 1 (4.8) 3 (14.3) 
Total 21 (100) 21 (100) 21 (100) 21 (100) 21 (100) 
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Table 4.14: Physician Beliefs regarding their Practices 
 Physician-Patient 
Communication 
Patient Health 
Literacy 
Patient Follow-Up 
 N (%) N (%) N (%) 
 Importance 
Not at all important 0 (0) 0 (0) 0 (0) 
Slightly important 0 (0) 0 (0) 0 (0) 
Important 0 (0) 1 (4.8) 0 (0) 
Very important 0 (0) 7 (33.3) 3 (14.3) 
Extremely important 21 (100) 13 (61.9) 18 (85.7) 
Total 21 (100) 21 (100) 21 (100) 
 Performance 
Very poor 0 (0) 0 (0) 0 (0) 
Poor 0 (0) 2 (9.5) 1 (4.8) 
Average 2 (9.5) 10 (47.6) 5 (23.8) 
Good 11 (52.4) 6 (28.6) 11 (52.4) 
Very good 8 (38.1) 2 (9.5) 4 (19.0) 
Total  21 (100) 20 (95.2) 21 (100) 
 Satisfaction 
Not satisfied at all 0 (0) 0 (0) 0 (0) 
Slightly satisfied 1 (4.8) 2 (9.5) 1 (4.8) 
Satisfied 4 (19.0) 10 (47.6) 6 (28.6) 
Very satisfied 10 (47.6) 7 (33.3) 9 (42.9) 
Extremely satisfied 6 (28.6) 2 (9.5) 5 (23.8) 
Total  21 (100) 21 (100) 21 (100) 
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Objective 4: To explore physicians’ challenges to overcome the barriers to self-management. 
 In order to identify the challenges physicians faced in managing their T2DM patients, the 
questionnaire further probed the major reasons of clinical inertia in their practices. ‘Clinical 
Inertia’ or ‘Therapeutic Inertia’ is defined as the lack of treatment intensification in patients who 
are not on “evidence-based goals” for care. The information was collected using open-ended 
questions and the analysis of this qualitative data was conducted to identify the common themes 
from the physicians’ and their medical staff members’ responses. Ryan and Bernard suggest 
various techniques to identify themes in qualitative research.71 Based on the nature of the 
responses collected in this survey, coding of responses into themes was performed using simple 
techniques such as: 
1. Repetitions: The words or phrases that were repeated in different responses were 
identified. Same thoughts expressed across responses irrespective of different wordings 
were also identified. 
2. Cutting and Sorting: The identified content within each theme was cut into individual ideas 
and sorted into subthemes.  
3. Similarities and Differences: The subthemes created were based on the similarities or 
difference between the ideas expressed. 
There were several themes that emerged from the physicians’ responses about the barriers that 
led to clinical inertia in their practice and these are summarized below.71, 72  
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a. Costs 
The most common theme resonating in the responses was the costs associated with managing 
T2DM. Cost of medications was the most cited barrier that led to clinical inertia. Other costs 
such as those incurred for office visits (due to copay issues), costs for purchasing insulin 
monitoring equipment, and additional costs associated with healthy food choices (lean proteins 
and vegetables) were also mentioned by the respondents as barriers to intensification of therapy 
in their T2DM patients. 
b. Patient Motivation and Interest 
A few respondents noted that lack of patient interest and their unwillingness to change their 
health-related behaviors prevented the practitioners from intensifying treatment and improving 
the health outcomes of their patients. Furthermore, as mentioned by one of the respondents, the 
lack of motivation from the patient made the practitioner pessimistic about being able to manage 
this type of patients. It was observed by another respondent that patients find it difficult ‘to curb 
their appetite for good tasting bad foods and prefer to watch TV than exercise’. Patient’s lack of 
confidence in guidelines, which are often inconsistent among various organizations that publish 
them, was cited as another reason for patient’s reluctance to change.  
c. Knowledge 
A respondent noted that there was lack of in-office diabetes education for the patients in their 
practice while another respondent found it difficult to get the patients to attend diabetes 
education outside of office visits. In general, the respondents believed that their patients did not 
feel they were ill or were in denial about their problems, some being unaware of secondary 
problems such as blindness and renal failure associated with unmanaged T2DM. Patients’ fear of 
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injectable medications and hypoglycemia also prevented their physicians from intensifying 
treatment.  
d. Non-compliance with Diet and Medications 
Patient’s non-compliance with diet, exercise and medications was cited as a barrier to treatment 
intensification by many respondents (47.62%). A respondent also mentioned that the patients do 
not keep up with scheduled visits and follow ups. 
e. Polypharmacy 
The respondents noted that their patients were already on multiple medications as part of their 
therapy and thus, it was difficult for the physicians to add more medications to their treatment 
regimen. Comorbidities often led to increased number of prescribed medications and could cause 
drug-drug interactions. Some patients were also reported to develop resistance to oral 
medications as well as insulin, making treatment difficult. A respondent mentioned that ‘newer 
medications and their changing roles caused the patients and providers to stick to old patterns’. 
All these factors associated with polypharmacy also lead to clinical inertia according to the 
survey respondents. 
f. Lack of Time 
The respondents acknowledged that they do not have enough time to focus on their patients’ 
diabetes related complications as the patients often have other chronic illnesses that require their 
attention during the office visits. Consequentially, the physicians have to let the patients work on 
their diet regimen and exercise, without being able to provide much care in that regard. They also 
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believed that the office visits were too few to be able to allocate enough time to address their 
patients T2DM related complications.  
g. Social support 
Family dynamics and lack of support from home (family members) to embrace a healthy lifestyle 
that includes proper diet regimen and regular exercise, was reported to be a barrier to treatment 
intensification by the physicians. 
h. Miscellaneous 
Apart from the aforementioned themes, barriers such as medication side-effects, reimbursement 
issues, and patients’ frustration due to not reaching goals or seeing immediate results were also 
reported by the respondents. 
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CHAPTER 5: DISCUSSION 
The current study provides a comprehensive assessment of barriers and facilitators to 
diabetes self-management from the perspectives of patients and their physicians. This chapter 
highlights the findings of this study, while comparing and contrasting them to existing literature. 
Additionally, this chapter details the conclusion of this study and provides directions for future 
research. 
This is one of the few studies to have utilized a mixed methods design (survey report to 
identify patient characteristics and self-care behaviors, and EMR to obtain clinical data) to 
identify patient perceived barriers and facilitators to DSM in a primary care setting. 
Supplementing the survey responses with the EMR data provides a unique advantage of 
validating self-reported survey responses using the EMR data. The data collected in this study 
have better validity than simple surveys since some self-reported variables captured in patient 
surveys were validated from the data obtained from patient records in the EMR.  Our analysis 
showed a strong correlation between the age observed in EMR and the survey reported age. The 
HbA1c level of the patients measured through survey report was also strongly correlated with 
their recent HbA1c recorded in EMR. This correlation was not as strong as age, as the survey 
reported HbA1c levels were approximations based on memory (measured twice a year by the 
physician practices), and there was also missing data. Another advantage of linking EMR data to 
the survey report was that it enabled us to use the HbA1c variable from EMR as a substitute for 
the survey recorded HbA1c to account for the higher proportion of missing values. 
The identification of sample and their inclusion for survey administration was carefully 
planned to include a heterogeneous group of patients with varying HBA1c values.  A stratified 
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sampling strategy was employed based on the patients’ HbA1c level as observed from their 
EMR. Three equal groups of 700 patients each were randomly selected from patients with 
HbA1c ≤ 7, 7.01 < HbA1c < 9, and HbA1c > 9, respectively. Among the respondents, the three 
groups were well represented (67, 82, and 37 respondents respectively), due to which all 
analyses were conducted across the three groups. The study population was predominantly 
Caucasian (94%) but the race distribution in the study sample, however, was consistent with the 
overall demographic distribution of Southwestern PA.73 Yet, caution should be exercised while 
generalizing the findings of this study in other settings with more diverse patients or comparing 
it with results from nationwide studies. Another issue with survey is the response rate. In this 
study, the response rate was 10% and thus, a question can arise if those who responded were 
different on measured characteristics to those who did not respond. The nonresponse bias was 
addressed by comparing early responders to late responders, since literature shows that late 
responders had characteristics similar to non-responders.74, 75 There was no significant difference 
seen between these two groups, which suggest that non-response bias may not be a threat to our 
study findings. 
 Glycemic control is an important clinical marker in the overall management of T2DM. In 
the multivariate regression analysis, it was found that patients with higher self-management 
(higher DSMQ score) were more likely to have better glycemic control compared to patients 
with poor self-management. This is consistent with previous literature that suggest a strong link 
between self-management and better glycemic control, and also with better quality of life and 
overall prognosis of disease.8 Another interesting observation was that patients younger than 50 
years were more likely to be uncontrolled than patients 65 years and older. This is contrary to 
existing knowledge that age is an important risk factor for poor glycemic control.76,77 However, a 
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recent US study using National Health and Wellness Survey (NHWS) found that glycemic 
control was the poorest in patients aged 18-64 years compared to older age groups.78  The authors 
suspected increasing medication adherence with age as a potential reason for better glycemic 
control in the older age group as compared to the 18-64 year olds. They also found that 
respondents in 18 to 64 year age group had higher lack of awareness of their HbA1c levels. 
Thus, both low knowledge and poor adherence could have contributed to these findings. A post-
hoc analysis of patient DSMQ scores across different age groups in our sample was conducted 
which revealed that a much lower proportion of patients aged 50 or younger (14.6%) reported 
high DSMQ scores compared to patients in the older age groups (31.3% and 33.2%, 
respectively) (p = 0.07) confirming our above inferences. Poor self-management in younger age 
group as compared to other age groups can help explain the poor glycemic control in these 
patients. Patients who showed low willingness to take insulin were less likely to be uncontrolled. 
This finding is consistent with previous literature that suggests that patients, who are 
uncontrolled despite using oral hypoglycemic agents and self-management tools, are more likely 
to receive insulin for more intensive blood glucose reduction.26, 79 Another observation that may 
seem counterintuitive was that patients with graduate level education were more likely to be 
uncontrolled than patients with college level education. There was no difference found in 
glycemic control among other categories of educational attainment. The evidence on the effect of 
educational attainment on glycemic control in the literature is mixed. Some studies have found 
educational status to be a strong predictor of glycemic control while others have found no 
association. 80, 81 The counterintuitive findings in this study makes sense, when combined with 
physician’s perceptions, according to whom, patients often do not seek follow-up care as they 
feel they have enough knowledge of their disease. 
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  Adherence has always been a challenge in any disease area with an average documented 
adherence rate of 24.8%.82 A variety of factors influence adherence rates including treatment-
related factors (dosing, administration, side effects), social and financial factors (copays, 
insurance coverage, access, social support), patient related factors (health literacy, motivation), 
health team and system factors (communication, provision of care), and condition specific 
factors (comorbidities, depression).82 Adherence is a patient-reported outcome and ultimately, 
the patient is responsible for keeping up with prescribed treatment regimens. Establishment of 
therapeutic relationship that improves patient knowledge and self-management skills is essential 
in improving adherence. It is also important to address patient motivation, which often is the 
hardest patient factor to target.78, 82 In this study, we assessed patient motivation and readiness to 
change self-management behaviors using a readiness ruler, where a majority of patients (67.9%) 
reported being in the “action” or “maintenance” phase of changing their diabetes-related self-
care behaviors. Moreover, the self-management scores reported on the DSMQ questionnaire 
were also high (> 5) for a majority of respondents (91.6%). Despite the higher readiness to 
change self-care behaviors, the patients were found to have low knowledge of diabetes on the 
DHL instrument with 75.7% patients unable to answer more than half the questions (> 5) 
correctly. The findings strongly suggest that these patients practice good self-management, and 
are willing to change their self-care behaviors, but a rate-limiting step in moving from 
“uncontrolled” to “controlled” HbA1c level could be their low knowledge regarding the disease. 
Use of multiple measures which can explore different aspects of patient knowledge may help 
tease out these differences. Clearly, this aspect needs to be further explored and if it is the case, 
then future interventions such as in-clinic diabetes education programs can be designed to 
selectively target these areas and improve patient knowledge of diabetes. These findings also 
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underscore the importance of comprehensive assessment of all these aspects of diabetes 
management to provide a complete picture of patient’s self-management behaviors. 
 In addition to knowledge of T2DM, attitudes and beliefs of patients about their treatment 
and illness are important determinants of self-management and glycemic control. The attitudes 
and beliefs of patients with better self-care behaviors have been found to be different from 
patients with poor self-care behaviors, and are more in accordance with the views of medical 
experts.85 Previous studies have also found strong associations between patient perceptions of 
their treatment and illness, and adherence to medications, diet and regular exercise.86 The current 
study employed the revised version of the Illness Perception Questionnaire (IPQ-R), an 
instrument validated in T2DM population.64 The responses on different domains within this scale 
suggest that a majority of patients perceived their disease to be chronic in nature, and a serious 
condition that had major consequences on their lives. They, however, believed that they could 
control the course of their illness, through proper treatment control. A majority of patients 
believed they understood their disease; which is in sharp contrast to their performance on the 
DHL questionnaire, where a majority of respondents demonstrated poor knowledge of the 
disease. This is indicative of patients perceiving good general awareness of their disease while, 
in fact, not having enough knowledge about the specific symptoms and risks associated with 
T2DM. This concern was also raised by their physicians in the physician survey, who cited 
patient’s perception of having adequate knowledge of diabetes as a reason for lack of follow-up 
care. A majority of patients reported that they do not have negative emotional representations 
with respect to T2DM, such as feeling upset, anxious, depressed, worried, afraid or angry 
because of their illness. A small proportion of patients (around 10-15%, refer Table 4.6), 
however, reported having at least one of these emotional representations. This warrants an 
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investigation about whether the attitudes and beliefs about T2DM in this population relate to 
outcomes such as self-management and glycemic control. Existing literature underscores the 
importance of attitudes and health beliefs in improving diabetes care outcomes, and some studies 
have suggested use of educational tools to modify these beliefs and improve DSM.85-88 The 
American Diabetes Association (ADA) has called for an individualized assessment and 
development of an educational plan, which takes into account relevant medical history, cultural 
influences, health beliefs and attitudes, diabetes knowledge, self-management skills and 
behaviors, readiness to learn, cognitive ability, physical limitations, family support, and financial 
status.88  
 Previous studies have shown that concordance between perceptions of patients and their 
physicians about self-care behaviors is associated with improved self-care.88 Successful 
management of T2DM requires collaborative efforts between patients an\d their physicians.89 
These efforts involve improving patient-physician communication, patient-health literacy, and 
addressing specific barriers to self-care in these patients.89-91 Pharmacist-led interventions such 
as Medication Therapy Management (MTM) services can be used to improve patient health 
literacy, overall self-management and self-efficacy in patients with T2DM.91 In addition to this, 
strategies and policies that focus on improving medication adherence in this population may 
have the potential for cost savings to the healthcare system and improved health outcomes to the 
patients.92 In this study, we sought to examine physician perceptions about self-care behaviors of 
their T2DM patients and the discordance between their perceptions and their patients’. The 
physician group in this study perceived the diabetes related self-care activities to be extremely 
important for overall management of T2DM; however, their perceptions about how difficult their 
patients perceived these activities varied considerably. The physicians acknowledged that 
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patient-physician communication, patient health literacy, and patient follow up are extremely 
important aspects of providing quality care to their patients; a majority of them considered the 
performance of their practices on these measures average or good, and a majority of them were 
at least satisfied with their performance. Physicians who rated their performance and satisfaction 
with patient follow-up and satisfaction with patient health literacy were more likely to consider 
themselves responsible for patients’ failure to achieve self-management goals. An area where the 
discordance between patient and physician perceptions was highlighted in this study was 
patients’ knowledge of the disease. Physicians cited that patients often do not seek follow-up 
care, as they perceive they have adequate knowledge of the disease. Interventions such as MTM 
services, or in-clinic patient education, can help identify and narrow such gaps in perceptions of 
patients and their providers. 
A sizable proportion of physicians considered inability to afford follow-up care as a 
reason for not seeking follow-up care by their patients. Our analysis showed that a higher 
proportion of patients with Medicaid as a source of insurance, privately insured patients and 
those with other sources of insurance had moderately or severely uncontrolled HbA1c levels, as 
compared to patients with Medicare as a source of insurance. This finding is contrary to a 
published retrospective study, which found that Medicare beneficiaries were more likely to be 
uncontrolled as compared to privately insured individuals.93 The mixed evidence regarding the 
association of type of insurance coverage with glycemic control may be due to systematic 
differences in the study populations. However, it is important to note that type of insurance 
coverage may affect receipt of follow-up care, and consequentially diabetes-management, and 
future studies should explore this association further. The physicians cited inability to control 
their patients’ HbA1c levels as a reason for referral to an endocrinologist. This is consistent with 
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the finding from the current patient survey that a higher proportion of patients who were 
moderately or severely uncontrolled received a referral to an endocrinologist.  
Key Takeaway Findings 
In this study, patient characteristics such as age, diabetes self-management, willingness to 
take insulin, educational status, insurance status, and referral to an endocrinologist were 
associated with glycemic control. Specifically, better self-management, as measured by DSMQ 
scores, older age, and higher education predicted optimal glycemic control. Diabetes self-
management and referral to an endocrinologist were also associated with the patient’s readiness 
to change their diabetes self-care behaviors. Physicians in this study perceived practice 
characteristics to be very/extremely important. Considerable variation was observed in their 
perceptions about performance and satisfaction about these characteristics. Self-care activities 
were perceived to be very important. Recommended diet and exercise were perceived to be more 
difficult to follow than adhering to insulin or oral medications.  
 The perceived knowledge of disease and illness coherence of patients measured by the 
IPQ-R questionnaire was high in a majority of the respondents; their performance on the DHL 
questionnaire, however, was poor, with a majority of respondents unable to answer more than 
50% questions correctly. This discrepancy in perceived knowledge and actual knowledge of the 
disease was highlighted by the physicians as well; they expressed frustration about patients not 
seeking follow-up care, thinking that they have enough knowledge of their disease. The 
pharmacist led intervention can target this area and focus on improving patient knowledge of 
their T2DM, through in clinic diabetes education.  
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Strengths 
This is one of the few studies that looked at the perspectives of both patients and their 
physicians for comprehensive assessment of patient barriers and facilitators to DSM. Moreover, 
few studies in the past have combined EMR data with self-reported survey data for assessment of 
barriers and facilitators to DSM. Combining these data enabled validation of survey responses 
through the variables in the EMR data, and also provided additional clinical information about 
the respondent, such as comorbidities, medications, and BMI, which would have been difficult to 
capture accurately through surveys alone. The stratified sampling technique employed in this 
study allowed us to get adequate responses from all three strata. The results of this study not only 
help identify the predictors of glycemic control in this population, but also identify areas of 
discordance between physicians and their patients. These aspects can serve as targets for 
interventions aimed at improving glycemic control and DSM in this population. 
Limitations 
 This study is not without limitations. The patient sample consisted of 210 responses, 
which translates to a 10% response rate, which is significantly lower than the response rates 
observed in the literature. However, this sample size was sufficient to conduct the proposed 
analyses. Non-response bias is a potential threat to the study findings, when responses are 
collected through mail-based surveys. There were no significant differences in the characteristics 
of early vs. responders, which suggest that non-response bias was not a threat to this study. The 
potential reason for a low response for this study, was the absence of multiple mailing and 
reminder post-card, in accordance with the Dillman survey method, due to funding constraints. 
The patient survey was also moderately long, requiring approximately 15 minutes of patient’s 
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time to complete. The potential respondent burden associated with the survey could have also 
contributed to the low response rate.  
 As with any other self-reported survey study, this study may have suffered from certain 
biases. Social desirability bias occurs when a respondent exaggerates, or hides a true response, 
because they are too embarrassed to reveal private information. In this study, the respondents 
were asked several questions about their attitudes, beliefs, and self-management behaviors, 
where their responses could have been biased. To avoid or minimize this bias, we employed 
standardized questionnaires validated in T2DM population, in the patient survey. The survey also 
captured clinical information such as the patient’s most recent HbA1c level, comorbidities, and 
so on. This could result in recall bias. A comparison of the HbA1c levels from self-report to the 
HbA1c levels recorded in EMR data showed a very high correlation, suggesting that recall bias 
was not a threat to this study. 
Future Directions 
The patient sample in this study is predominantly Caucasian. Though this sample is 
representative of southwestern PA, the generalizability of the study findings to other, more 
diverse populations, is suspect. Future studies should replicate this study in larger, more diverse 
samples, and examine if the findings are consistent with the current study. As a natural next step 
to this study, a pharmacist led intervention that targets the identified predictors, and specifically 
focuses on improving patient knowledge of their disease, could be implemented. A cost-benefit 
analysis of this intervention can then be performed to assess its effectiveness, and examine if it is 
feasible to implement such an intervention on a larger scale.  
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Overall Conclusions 
The findings of this study underscore the importance of DSM in the overall management 
of T2DM. Understanding the barriers and facilitators to DSM, common to patients and their 
providers, while also identifying and addressing the discordance between them regarding various 
aspects of patient care can improve care and outcomes. Interventions including clinical services 
that facilitate collaborative relationships between providers and their patients are crucial in 
enhancing the overall management of T2DM.  
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